L04AX Other immunosuppressants

RX_L04AX

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L04AX 1 out of 7 registries used, show all original rules.	33711
4. Check minimum number of events Min. number of events 3	33711
5. Include endpoints None	33711
6. Filter based on genotype QC (FinnGen only)	30345

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	RX_L04AX
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L04AX
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to L04AX Other immunosuppressants based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	30345	18843	11502
Unadjusted period prevalence (%)	6.15	6.69	5.27
Median age at first event (years)	53.87	52.64	55.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
31289: Matched controls
312608

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

26.3

322.4

222

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.3

318.2

656

1269

R4180

NOMESCO Finland

Podiatric therapy

5.6

317.1

606

1094

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

314.9

3393

17193

9522

FHL

Synovectomy

25.4

311.3

217

XW000

NOMESCO Finland

Bone marrow biopsy

3.0

310.8

1452

5007

M05BX04

ATC

denosumab; parenteral

2.5

309.9

2063

8536

L01CB

ATC

Podophyllotoxin derivatives

30.5

309.8

203

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

309.4

5723

34700

M01CB03

ATC

auranofin; oral

24.3

307.7

700

294

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

4.0

307.7

1880

4923

L04AA33

ATC

[U] vedolizumab

29.4

307.7

225

A07EC02

ATC

mesalazine; oral, rectal

7.5

307.7

4292

6448

L04AB04

ATC

adalimumab; parenteral

60.0

307.7

4016

765

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

12.5

307.7

646

527

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

10.4

307.7

1066

1054

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

41.0

307.7

1336

340

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

22.0

307.7

569

263

3005

Kela drug reimbursment

Tofacitinib

51.5

307.7

397

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.3

307.7

2251

4482

M25.5

ICD-10 Finland

Pain in joint

2.0

307.7

12097

75405

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

57.8

307.7

579

102

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

7.2

307.7

487

689

356

Kela drug reimbursment

Nintedanib and pirfenidone

20.9

307.7

382

185

L04AC18

ATC

risankizumab; parenteral

50.5

307.7

315

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

11.5

307.7

617

544

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

44.7

307.7

354

134

Kela drug reimbursment

General erythroderma

19.2

307.7

287

151

L20

ICPC

Joint symptom/complaint NOS

3.4

307.7

1795

5557

UJF30

NOMESCO Finland

Ileoscopy through colon

3.0

307.7

4872

17861

WZA10

NOMESCO Finland

Extensive medical or dental certificate

10.7

307.7

1147

1112

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

31.0

307.7

1084

361

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

53.2

307.7

3101

645

329

Kela drug reimbursment

Lenalidomide

98.0

307.7

559

N07XX09

ATC

[U] dimethyl fumarate

42.7

307.7

271

K51.8

ICD-10 Finland

Other ulcerative colitis

10.3

307.7

1108

1113

253, ,

Kela drug reimbursment

25.0

307.7

349

141

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

22975

172861

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

17.9

307.7

792

453

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

8.1

307.7

1873

2432

L04AA06

ATC

mycophenolic acid; systemic

6.8

307.7

1304

1987

M06

ICD-10 Finland

Other rheumatoid arthritis

45.7

307.7

764

171

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

307.7

13079

95249

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

307.7

2988

13791

D05AX02

ATC

calcipotriol; topical

5.9

307.7

2216

3999

ZX120

NOMESCO Finland

Intravenous

4.0

307.7

4832

13741

M01CB01

ATC

sodium aurothiomalate; parenteral

38.4

307.7

1619

444

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.3

307.7

4226

9023

M45

ICD-10 Finland

Ankylosing spondylitis

10.5

307.7

1756

1761

4AA12, ,

NOMESCO Finland

77.3

307.7

435

L01BA01

ATC

methotrexate; systemic

69.9

307.7

6442

1156

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

21.8

307.7

380

176

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.1

307.7

2614

8797

L04AA37

ATC

[U] baricitinib

75.6

307.7

270

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

16.5

307.7

902

563

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

15.2

307.7

1756

1220

L04AX03

ATC

methotrexate; systemic

403.2

307.7

23885

2481

L04AA01

ATC

[U] ciclosporin

22.1

307.7

1522

722

K50

ICD-10 Finland

Crohn disease [regional enteritis]

18.5

307.7

378

207

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.8

307.7

855

1803

M01AC06

ATC

meloxicam; systemic, rectal

1.7

307.7

11185

77924

RT272, ,

NOMESCO Finland

22.3

307.7

310

140

RT271, ,

NOMESCO Finland

27.8

307.7

224

TGC00

NOMESCO Finland

Bronchial lavation

3.9

307.7

1055

2796

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

11.5

307.7

4648

4672

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

21.3

307.7

354

168

L04AC14

ATC

sarilumab; systemic

92.9

307.7

249

H26.3

ICD-10 Finland

Drug-induced cataract

9.8

307.7

405

418

L40.0

ICD-10 Finland

Psoriasis vulgaris

7.6

307.7

3339

4843

291

Kela drug reimbursment

Tofacitinib

84.0

307.7

374

L04AA17

ATC

[U] adalimumab

56.0

307.7

404

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

37.9

307.7

1712

477

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.9

307.7

3835

14215

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

7398

47084

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.3

307.7

1369

4336

C90.0

ICD-10 Finland

Multiple myeloma

15.0

307.7

795

543

L04AK01

ATC

leflunomide; oral

40.8

307.7

889

224

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

27.5

307.7

303

111

L04AX07

ATC

dimethyl fumarate; oral

224.7

307.7

574

G35

ICD-10 Finland

Multiple sclerosis

5.3

307.7

832

1607

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

23.3

307.7

9290

5558

K50.0

ICD-10 Finland

Crohn disease of small intestine

16.5

307.7

1592

1015

H02AB04

ATC

methylprednisolone; systemic

2.5

307.7

5550

25276

D94

ICPC

Chronic enteritis/ulcerative colitis

9.0

307.7

542

609

L04AX04

ATC

lenalidomide; oral

147.2

307.7

734

L04AC16

ATC

guselkumab; systemic

54.1

307.7

279

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.1

307.7

1432

4697

R50.9

ICD-10 Finland

Fever, unspecified

2.1

307.7

5344

28332

L04AA11

ATC

[U] etanercept

51.5

307.7

462

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

28.1

307.7

318

114

L04AC13

ATC

ixekizumab; parenteral

51.4

307.7

451

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

7.0

307.7

809

1180

K51.5

ICD-10 Finland

Left sided colitis

10.7

307.7

2504

2515

K50.8

ICD-10 Finland

Other Crohn disease

21.6

307.7

1824

893

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

5.2

307.7

772

1509

L04AC10

ATC

secukinumab; parenteral

36.4

307.7

593

166

D07XC01

ATC

betamethasone; topical

2.9

307.7

5017

19532

A07EA02

ATC

hydrocortisone; rectal

8.3

307.7

1558

1964

E000001, ,

ATC

1.8

307.7

6355

38365

153

Kela drug reimbursment

Lenalidomid

95.2

307.7

726

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

13645

96617

L04AB06

ATC

golimumab; parenteral

53.1

307.7

1286

252

D05BB02

ATC

acitretin; oral

7.7

307.7

1564

2132

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

6.9

307.7

1032

1531

J01FF01

ATC

clindamycin; systemic

1.7

307.7

8502

56362

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

8.9

307.7

1444

1691

M01AH01

ATC

celecoxib; oral

2.0

307.7

5874

33063

L88

ICPC

Rheumatoid/seropositive arthritis

55.0

307.7

7362

1738

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

43.9

307.7

4053

1055

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

307.7

4598

22629

E0000UV, ,

ATC

1.9

307.7

14347

97554

UJF92

NOMESCO Finland

Capsular endoscopy

4.3

307.7

1051

2491

L04AB05

ATC

certolizumab pegol; parenteral

57.4

307.7

702

125

3042, ,

Kela drug reimbursment

24.8

307.7

349

142

ZX140

NOMESCO Finland

Intra articular

14.8

307.7

632

435

A07EC01

ATC

sulfasalazine; oral, rectal

31.8

307.7

12178

6133

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

307.7

19629

103527

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

7248

43383

L04AB02

ATC

infliximab; parenteral

41.6

307.7

692

170

L04AA32

ATC

apremilast; oral

32.0

307.7

345

109

D07AC13

ATC

mometasone; topical

1.7

307.7

8956

60683

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

13788

98342

L04AA24

ATC

abatacept; parenteral

82.4

307.7

678

NDL52

NOMESCO Finland

Tenosynovectomy of hand

14.0

307.7

545

395

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

5.9

307.7

698

1203

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

18.4

307.7

393

216

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

24.8

307.7

891

369

L04AX05

ATC

pirfenidone; oral

193.2

307.7

382

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

307.7

4697

25060

P01BA02

ATC

hydroxychloroquine; oral

29.9

307.7

12255

6589

D05AX03

ATC

calcitriol; topical

8.2

307.7

819

1018

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

14.1

307.7

444

319

L04AX01

ATC

azathioprine; systemic

87.4

307.7

8592

1348

3029

Kela drug reimbursment

Upadacitinib

47.9

307.7

388

L01BB02

ATC

mercaptopurine; oral

8.9

307.7

888

1020

TQW80

NOMESCO Finland

Local dermatologic skincare

4.1

307.7

1221

3076

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

26.8

307.7

10140

5490

L04AD01

ATC

ciclosporin; systemic

15.7

307.7

1899

1281

L40.5

ICD-10 Finland

Arthropathic psoriasis

39.6

307.7

2448

668

L40.8

ICD-10 Finland

Other psoriasis

7.7

307.7

482

630

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

5.7

307.7

849

1530

L40

ICD-10 Finland

Psoriasis

5.2

307.7

1045

2047

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

307.7

13718

102740

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

36.8

307.7

4437

1396

M13.0

ICD-10 Finland

Polyarthritis, unspecified

11.3

307.7

958

874

D05AX52

ATC

calcipotriol, combinations; topical

5.8

307.7

3576

6848

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

8.4

307.7

684

828

293

Kela drug reimbursment

Baricitinib

77.1

307.7

283

284

Kela drug reimbursment

Nintedanib and pirfenidone

21.9

307.7

388

179

WZC30

NOMESCO Finland

Teaching

1.9

307.7

5468

31442

M35.1

ICD-10 Finland

Other overlap syndromes

15.4

307.7

365

239

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

12.2

307.7

912

767

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.2

307.7

1876

4631

M01AH05

ATC

etoricoxib; oral

1.6

307.7

19770

160672

M31.3

ICD-10 Finland

Wegener granulomatosis

27.6

307.7

326

119

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

9.2

307.7

1392

1577

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

75.8

307.7

1358

187

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

42.9

307.7

767

183

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

307.7

3677

15791

D07AC01

ATC

betamethasone; topical

1.8

307.7

12178

81034

4AB02, ,

NOMESCO Finland

92.5

307.7

501

R4110

NOMESCO Finland

Physiotherapy

1.7

307.7

8646

57817

M07.3

ICD-10 Finland

Other psoriatic arthropathies

51.3

307.7

1459

298

M13.9

ICD-10 Finland

Arthritis, unspecified

8.7

307.7

6652

9360

L04AA29

ATC

[U] tofacitinib

54.6

307.7

410

298, ,

Kela drug reimbursment

50.1

307.7

372

H02AB07

ATC

prednisone; oral

4.0

307.7

7030

21288

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.9

307.7

5927

14123

K50.1

ICD-10 Finland

Crohn disease of large intestine

19.9

307.7

1327

694

UJF32

NOMESCO Finland

Coloscopy

2.2

307.7

9490

51401

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

8.5

307.7

2469

3131

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

35.2

307.7

345

L04AF03

ATC

upadacitinib; oral

38.7

307.7

326

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

12.8

307.7

1856

1527

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

33.9

307.7

1538

476

D07AD01

ATC

clobetasol; topical

2.2

307.7

6295

32276

K50.9

ICD-10 Finland

Crohn disease, unspecified

16.6

307.7

1557

983

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.7

307.7

915

2010

L04AA44

ATC

[U] upadacitinib

62.3

307.7

229

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.4

307.7

1028

1950

NH3AE

NOMESCO Finland

Feet ultrasound examination

22.7

307.7

299

133

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.3

307.7

505

703

H02AB09

ATC

hydrocortisone; systemic

4.3

307.7

1170

2781

L04AA13

ATC

[U] leflunomide

53.4

307.7

3912

834

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.7

307.7

1025

2217

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

14.8

307.7

693

478

L04AG05

ATC

vedolizumab; parenteral

24.1

307.7

285

119

S91

ICPC

Psoriasis

9.5

307.7

658

704

L04AB01

ATC

etanercept; parenteral

59.8

307.7

2642

481

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

36.3

307.7

238

A07EA06

ATC

budesonide; oral, local oral

8.8

307.7

3330

4162

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

10.4

307.7

528

516

H20.1

ICD-10 Finland

Chronic iridocyclitis

9.1

307.7

738

832

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

8.5

307.7

885

1063

256, ,

Kela drug reimbursment

36.0

307.7

325

L40.9

ICD-10 Finland

Psoriasis, unspecified

5.4

307.7

884

1664

R4120

NOMESCO Finland

Occupational therapy

3.1

307.7

2845

9738

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

12.5

307.7

611

496

M05BA07

ATC

risedronic acid; oral

3.9

307.7

1142

3021

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

17.3

307.7

310

181

L04AC07

ATC

tocilizumab; parenteral

59.9

307.7

496

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

30.2

307.7

371

124

J01DB01

ATC

cefalexin; oral

1.9

307.7

26214

228051

L01BB01, ,

ATC

167.2

307.7

282

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

9.2

307.7

671

743

L04AC05

ATC

ustekinumab; parenteral

38.3

307.7

708

189

M05BA04

ATC

alendronic acid; oral

3.9

307.7

3882

11091

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

67.7

307.7

9134

1891

M13.8

ICD-10 Finland

Other specified arthritis

8.0

307.7

647

827

XX9XE

NOMESCO Finland

Other ultrasound examination

18.8

307.7

871

476

NDG30

NOMESCO Finland

Fusion of wrist, total

20.7

307.7

467

229

NG1DA

NOMESCO Finland

X-ray of knees

5.9

307.7

1005

1763

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

45.8

307.7

268

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.7

307.7

17269

64695

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

69.5

307.7

20011

7781

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

307.7

9483

59247

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

41.5

307.7

3257

873

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

6.1

307.7

746

1249

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

43.5

307.7

963

228

109

Kela drug reimbursment

Multiple sclerosis

7.6

307.7

737

990

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

10.9

307.7

352

327

TNG10

NOMESCO Finland

Puncture of knee

22.6

307.7

1252

576

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

44.6

307.7

622

142

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

72.0

307.7

5646

953

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

26.1

307.7

603

235

3006

Kela drug reimbursment

Baricitinib

73.5

307.7

306

K51

ICD-10 Finland

Ulcerative colitis

7.3

307.7

645

893

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

72.2

307.7

5336

888

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

22.2

307.7

591

271

127

Kela drug reimbursment

Transplant complication

5.4

307.7

847

1608

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

9.4

307.7

1974

2234

NH3EA

NOMESCO Finland

Feet X-ray examination with load

13.1

307.7

1871

1515

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

57.3

307.7

624

111

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

6.7

307.7

865

1326

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.4

307.7

778

950

H02AB06

ATC

prednisolone; systemic

6.9

307.7

24290

104172

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.4

307.7

7375

14461

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.7

307.7

2375

6701

J01MA02

ATC

ciprofloxacin; systemic

1.6

303.2

11379

82874

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

7.8

298.8

417

543

L04AF01

ATC

tofacitinib; oral

79.8

298.5

159

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

298.2

2525

11619

9256

FHL

Synovectomy (knee 9311)

29.7

295.2

195

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

294.5

2837

13753

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

294.1

1674

6412

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

291.7

1874

7619

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

290.2

2647

12553

WW200

NOMESCO Finland

Immunization

3.3

288.6

1113

3425

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

11.5

287.8

298

261

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

10.8

287.2

310

289

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

38.4

287.1

176

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

285.0

1013

2960

ND1AE

NOMESCO Finland

Wrist ultrasound examination

13.2

284.3

270

206

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

4.0

283.3

839

2165

H02AB08

ATC

triamcinolone; systemic

13.8

283.3

262

191

299, ,

Kela drug reimbursment

57.0

282.9

159

Z3231

NOMESCO Finland

Registered nurse

1.6

281.8

8145

55515

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

35.2

278.7

175

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

278.4

3140

16143

Z3226

NOMESCO Finland

Physiotherapist

1.8

277.6

5456

33550

L04AC21

ATC

bimekizumab; systemic

57.6

276.3

155

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

16.8

275.3

229

137

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

5.5

274.4

532

973

Z94.0

ICD-10 Finland

Kidney transplant status

5.3

273.9

557

1064

N02BE01

ATC

paracetamol; systemic, rectal

1.9

271.8

27713

251294

M34.1

ICD-10 Finland

CR(E)ST syndrome

11.6

271.3

280

244

J05AB01

ATC

aciclovir; systemic

1.7

270.4

6808

44734

D07AB08

ATC

desonide; topical

2.0

269.6

3473

18702

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

268.7

6816

44864

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

267.5

13311

102342

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

267.3

2489

11887

J05AB11

ATC

valaciclovir; oral

1.8

267.2

4660

27641

1XC02, ,

NOMESCO Finland

7.8

257.6

357

461

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.7

253.7

1406

5306

NDF10

NOMESCO Finland

Synovectomy of wrist

27.0

252.2

172

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

16.9

250.4

208

124

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

5.4

249.0

496

930

M12.3

ICD-10 Finland

Palindromic rheumatism

15.6

248.3

215

139

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

14.5

246.8

222

154

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

15.5

246.6

214

139

7151

FHL

Kidney transplantation

106.2

246.6

127

M06.3

ICD-10 Finland

Rheumatoid nodule

45.5

246.3

145

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

239.0

1393

5390

RK220, ,

NOMESCO Finland

12.0

238.6

240

201

A02BC03

ATC

lansoprazole; oral

1.6

237.5

8129

57242

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.8

236.9

440

773

RT310, ,

NOMESCO Finland

43.9

235.9

140

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

235.1

9186

66580

318

Kela drug reimbursment

Teriparatide

8.8

233.1

293

336

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

31.6

233.0

151

WW300

NOMESCO Finland

Transfer of autologic stem cells

10.9

233.0

250

231

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

232.1

3762

21752

S18

ICPC

Laceration/cut

1.5

231.4

13950

110397

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

229.9

1225

4526

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

6.2

228.6

395

647

L99

ICPC

Musculoskeletal disease other

3.3

227.9

885

2732

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

16.5

227.8

191

116

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

226.4

8811

63699

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

225.6

2031

9548

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

38.5

225.1

138

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.5

225.0

1435

5799

M17.5

ICD-10 Finland

Other secondary gonarthrosis

4.3

224.9

590

1391

A04AA01

ATC

ondansetron; systemic, rectal

2.0

224.7

2681

14012

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

7.0

224.7

344

497

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

39.3

224.7

137

K75.4

ICD-10 Finland

Autoimmune hepatitis

14.5

223.9

201

139

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

222.4

3865

22802

D02AE01

ATC

carbamide; topical

2.2

221.2

2038

9667

C10AC01

ATC

colestyramine; oral

3.0

221.2

1037

3575

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

220.5

3339

18885

9284

FHL

Wrist ossification surgery

31.7

219.3

142

J01MA12

ATC

levofloxacin; systemic

1.7

219.0

5158

33088

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

12.0

218.9

220

184

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

10.5

218.8

240

229

B03XA01

ATC

erythropoietin; parenteral

6.4

218.7

363

571

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

218.3

2499

12865

393

Kela drug reimbursment

Pomalidomide

719.6

218.0

215

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

217.8

917

2972

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

29.5

217.5

144

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

24.2

216.9

154

L04AF02

ATC

baricitinib; oral

87.9

216.5

114

PAW37

NOMESCO Finland

Biopsy of temporal artery

7.2

215.9

321

449

WX002

NOMESCO Finland

Sedation and analgesia

1.6

215.4

5408

35248

B01AB05

ATC

enoxaparin; parenteral

1.5

215.2

8944

65422

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

4.9

214.8

474

972

H05AA02

ATC

teriparatide; parenteral

8.8

214.6

270

310

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

20.6

214.0

162

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.6

213.9

733

2089

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

15.8

213.5

183

116

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

18.4

213.3

170

Z2221

NOMESCO Finland

Medical doctor

1.5

212.6

7927

56629

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

32.0

212.2

137

L04AX06

ATC

pomalidomide; oral

1040.0

211.5

207

4AA33, ,

NOMESCO Finland

39.2

211.4

129

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.7

209.3

264

304

L04AD02

ATC

tacrolimus; systemic

4.6

209.3

498

1087

M33.2

ICD-10 Finland

Polymyositis

19.3

209.1

163

L34

ICPC

Musculoskeletal, Blood test

46.7

206.6

121

1507

Kela drug reimbursment

Pomalidomide

682.4

206.6

204

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.8

206.5

472

997

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

7.0

206.2

316

457

E000003, ,

ATC

2.4

204.4

1421

5974

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.7

203.6

477

1028

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

203.1

1177

4536

P01BA01

ATC

chloroquine; systemic

9.0

202.9

251

282

ZXE00

NOMESCO Finland

One hour or less

1.5

202.0

11076

85356

XPX04

NOMESCO Finland

Angioscopy

8.5

200.3

258

305

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

198.6

11268

87324

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

7.0

198.2

304

440

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

197.3

2157

10907

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

18.6

197.2

156

XQ848

NOMESCO Finland

Dermatological photography

2.8

197.0

1011

3659

M19.2

ICD-10 Finland

Other secondary arthrosis

4.1

196.5

556

1387

M01CC01

ATC

penicillamine; oral

21.7

195.9

145

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.6

194.9

1170

4588

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

194.0

9897

75078

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

32.1

193.9

125

L01AA03

ATC

melphalan; systemic

27.0

193.6

132

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

193.3

2924

16496

E000002, ,

ATC

1.8

192.6

3295

19296

M08.8

ICD-10 Finland

Other juvenile arthritis

59.6

191.7

107

NDG74

NOMESCO Finland

Fusion of first IP joint

11.9

191.7

194

164

ZX112

NOMESCO Finland

Subcutaneous

3.3

191.7

753

2340

RK210, ,

NOMESCO Finland

13.3

190.6

180

136

N03AX16

ATC

[U] pregabalin

1.5

189.7

6551

45840

M01AH02

ATC

rofecoxib; oral

1.8

189.5

3453

20587

M01AE02

ATC

naproxen; oral, rectal

1.4

189.5

16884

141500

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

187.5

11465

89816

A02BC01

ATC

omeprazole; systemic

1.5

187.0

7542

54515

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

20.4

186.7

142

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

184.9

2756

15466

C03CA01

ATC

furosemide; systemic

1.5

183.4

7101

50861

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

45.1

183.0

108

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

20.1

182.9

140

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

182.6

1306

5557

L01AA01

ATC

cyclophosphamide; systemic

10.4

180.2

200

194

RS221, ,

NOMESCO Finland

3.8

177.9

551

1466

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

177.7

3413

20630

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

9.5

176.9

209

221

K71

ICPC

Rheumatic fever/heart disease

46.9

176.0

103

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

19.0

175.8

138

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.7

175.4

556

1503

J01CA04

ATC

amoxicillin; systemic

1.5

175.3

25017

226712

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.6

174.8

584

1636

7143D

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]

27.1

174.7

119

JF1BD

NOMESCO Finland

Very extensive small bowel CT

6.8

174.4

274

407

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

174.0

2053

10652

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

173.7

6583

46858

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

48.2

173.6

101

M05.0

ICD-10 Finland

Felty syndrome

25.6

172.7

120

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

171.7

6729

48211

P01AB01

ATC

metronidazole; oral, rectal

1.4

169.8

11663

92788

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

7.5

168.8

243

328

A02BC05

ATC

esomeprazole; systemic

1.4

167.5

11650

92821

4AC07, ,

NOMESCO Finland

81.1

167.1

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

3.8

167.0

523

1402

SPAT1202

SPAT

Intra-articular injection

2.7

166.7

934

3536

108

Kela drug reimbursment

Myasthenia gravis

10.5

166.6

183

175

RT171, ,

NOMESCO Finland

16.9

166.4

138

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

10.3

165.7

185

181

L04AX02

ATC

thalidomide; oral

65.1

165.4

S97

ICPC

Chronic ulcer skin

2.0

164.0

1771

8897

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.3

164.0

331

628

SPAT1153

SPAT

Removal of sutures

1.4

163.9

8473

63979

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.9

163.8

786

2742

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

38.5

163.1

100

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

162.7

5485

38009

A07EA01

ATC

prednisolone; oral, rectal

6.5

161.8

264

408

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

161.1

4310

28329

G70.0

ICD-10 Finland

Myasthenia gravis

8.3

160.8

212

258

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

160.7

2110

11344

M05BA06

ATC

ibandronic acid; systemic

3.3

160.7

611

1860

ZX108

NOMESCO Finland

Inhalation

5.3

160.6

325

618

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

160.0

834

3041

L95

ICPC

Osteoporosis

2.4

159.6

1199

5210

JF1AD

NOMESCO Finland

Small bowel CT

5.2

157.4

323

622

NF1DA

NOMESCO Finland

X-ray of hips

3.0

157.3

697

2325

L40.4

ICD-10 Finland

Guttate psoriasis

6.7

156.8

248

371

9527

FHL

Alloarthroplasty, implant or endoprosthesis

38.5

156.5

3AC01, ,

NOMESCO Finland

4.5

156.1

383

857

D05AA

ATC

Tars

6.3

156.1

262

417

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.3

154.8

594

1819

ZXA00

NOMESCO Finland

Right side

1.5

154.7

6803

49719

WX204

NOMESCO Finland

Axillary plexus blockaced

2.5

154.6

1053

4379

NHG22

NOMESCO Finland

Fusion of subtalar joint

5.4

154.3

305

568

ZZH31

NOMESCO Finland

Bone allograft, small pieces

5.1

153.8

325

642

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

153.6

2899

17397

D02AX

ATC

Other emollients and protectives

2.5

153.3

1010

4136

L03AB07

ATC

interferon beta-1a; parenteral

5.8

153.2

281

488

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

8.6

152.8

195

228

WX320

NOMESCO Finland

Spinalanesthesy

1.5

152.6

6731

49199

RJ421, ,

NOMESCO Finland

8.2

152.3

201

245

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

152.2

2293

12876

B07.9

ICD-10 Finland

Verruca simplex

2.3

149.9

1233

5567

L03AX13

ATC

glatiramer acetate; parenteral

6.7

149.3

237

356

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

9.6

148.8

175

184

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

27.4

148.7

101

M31.1

ICD-10 Finland

Thrombotic microangiopathy

22.6

148.1

108

A46

ICD-10 Finland

Erysipelas

1.6

147.9

3920

25665

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

147.1

2760

16526

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

6.7

146.8

234

353

M02.8

ICD-10 Finland

Other reactive arthropathies

6.5

146.8

241

375

A07EC03

ATC

olsalazine; oral

11.9

144.6

146

123

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

36.1

144.2

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

144.1

1066

4599

M01AB55

ATC

diclofenac, combinations; oral

2.0

144.0

1756

9199

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.4

143.9

237

370

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

143.5

2058

11374

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

143.0

1357

6487

A02BA02

ATC

ranitidine; systemic

1.5

142.6

4827

33372

L01FC01

ATC

daratumumab; parenteral

41.0

142.4

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

25.4

142.1

ND2CG

NOMESCO Finland

Extensive MRI of hand

8.2

142.0

188

230

4AA24, ,

NOMESCO Finland

60.9

141.9

RJ411, ,

NOMESCO Finland

6.2

141.8

243

395

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

37.9

141.2

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

140.2

1736

9141

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

139.8

1365

6597

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.0

139.0

613

2039

S01BA01

ATC

dexamethasone; ophthalmic

2.4

138.7

1023

4407

N03AX12

ATC

[U] gabapentin; oral

1.5

138.5

4414

30102

ZY010

NOMESCO Finland

Hospital outpatient

2.0

137.9

1577

8076

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

137.7

803

3100

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.4

137.7

499

1474

B02.9

ICD-10 Finland

Zoster without complication

1.9

137.1

1937

10650

S01BA04

ATC

prednisolone; ophthalmic

3.0

137.0

633

2162

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

136.9

663

2324

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

136.7

6125

44764

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

8.3

136.6

180

219

H46

ICD-10 Finland

Optic neuritis

4.4

136.5

344

786

Z2446

NOMESCO Finland

Social worker

1.9

136.3

1839

9962

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

134.8

1924

10610

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

6.1

134.8

233

382

5BA08, ,

NOMESCO Finland

6.4

134.6

222

347

M79.6

ICD-10 Finland

Pain in limb

1.3

134.6

12925

107246

M33.1

ICD-10 Finland

Other dermatomyositis

20.7

133.6

101

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

11.2

133.5

140

125

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

133.5

1650

8679

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

8.3

133.3

175

212

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

12.8

132.8

128

100

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

132.4

3551

23270

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.0

132.2

375

937

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

131.8

10107

80942

J01MA14

ATC

moxifloxacin; systemic

1.7

131.2

2421

14409

137

Kela drug reimbursment

Uraemia requiring dialysis

4.4

131.2

327

741

N02AA05

ATC

oxycodone; systemic

1.5

131.1

4523

31344

N86

ICPC

Multiple sclerosis

4.9

131.0

287

585

L12.0

ICD-10 Finland

Bullous pemphigoid

6.0

130.2

229

382

TAB00

NOMESCO Finland

Lumbar puncture

2.1

129.9

1337

6588

9272

FHL

Metatarsophalangeal joint resection

9.4

129.7

154

164

A05AA02

ATC

ursodeoxycholic acid; oral

3.0

129.1

583

1965

L28

ICPC

Limited function/disability (L)

1.5

128.7

4846

34182

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

128.2

3246

20968

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

16.1

128.2

109

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

13.2

127.6

121

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

127.5

640

2287

1XX32, ,

NOMESCO Finland

40.6

127.1

M06.1

ICD-10 Finland

Adult-onset Still disease

21.2

126.9

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

126.6

15331

131164

M16.7

ICD-10 Finland

Other secondary coxarthrosis

4.5

126.3

314

710

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

4.6

125.9

299

652

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

125.4

3722

24943

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

124.7

10826

88165

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

11.6

124.4

128

111

Z94.4

ICD-10 Finland

Liver transplant status

7.0

124.0

189

272

WVA20

NOMESCO Finland

Medicine administration

2.4

123.6

877

3712

M01AX01

ATC

nabumetone; oral

2.1

122.6

1154

5496

NDG76

NOMESCO Finland

Fusion of DIP joint

4.2

122.1

327

783

L17

ICPC

Foot/toe symptom/complaint

1.4

122.1

8782

69426

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.8

122.0

383

1029

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

121.8

763

3049

N07AA02

ATC

pyridostigmine; systemic

5.9

121.7

220

377

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

121.4

772

3107

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

37.6

121.4

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.8

121.3

602

2138

L88

ICD-10 Finland

Pyoderma gangrenosum

9.4

120.9

144

154

YNB10

NOMESCO Finland

Collection of stem cells for transplant

13.1

120.8

115

M01AX17

ATC

nimesulide; oral

1.4

120.3

6064

45145

5550A

ICD-9 Finland

Regional enteritis, Small intestine

23.3

119.4

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

119.1

5347

38962

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

13.8

119.0

110

C08CA05

ATC

nifedipine; systemic

1.9

118.8

1469

7721

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

118.2

3647

24625

R06.0

ICD-10 Finland

Dyspnoea

1.4

118.1

7245

55759

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

16.5

118.1

SPAT1255

SPAT

Intravenous administration of medicine

1.8

117.9

1772

9920

RJ410, ,

NOMESCO Finland

6.8

117.7

183

269

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.4

117.6

427

1263

M31.7

ICD-10 Finland

Microscopic polyangiitis

17.1

117.5

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

117.3

751

3032

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

36.6

117.3

ZXA05

NOMESCO Finland

Left side

1.4

117.2

6127

45877

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

117.2

3890

26682

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

117.0

1486

7881

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

116.9

11330

93517

2AB04, ,

NOMESCO Finland

9.3

116.8

140

151

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

116.6

2784

17706

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

116.3

1772

9961

M05BA01

ATC

etidronic acid; systemic

6.2

116.2

197

317

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.1

115.6

491

1598

J01AA02

ATC

doxycycline; systemic

1.3

115.0

22476

204475

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

114.7

2961

19187

J01FA06

ATC

roxithromycin; oral

1.3

114.7

10743

88167

E000007, ,

ATC

1.9

114.4

1530

8252

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

113.7

4216

29571

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

25.5

113.5

A12AA04

ATC

calcium carbonate; oral

3.1

113.3

472

1519

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

5.2

110.9

228

440

ZXX08

NOMESCO Finland

Extent of procedure, 8 units

17.2

110.7

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

110.5

1058

5070

H30.2

ICD-10 Finland

Posterior cyclitis

7.4

109.9

158

213

SPAT1325

SPAT

Vaccination

1.3

109.9

8472

67454

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

108.9

15208

131545

E000006, ,

ATC

1.8

108.5

1811

10454

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.8

108.4

328

859

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

25.9

108.3

M34.0

ICD-10 Finland

Progressive systemic sclerosis

15.1

108.2

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

107.8

7280

56757

RJ511, ,

NOMESCO Finland

9.8

107.5

124

127

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

8.0

107.3

145

182

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

107.2

6966

53975

ZXD05

NOMESCO Finland

Urgent procedure

1.4

106.7

7869

62175

SPAT1229

SPAT

Assessment of need for aid

1.8

106.6

1838

10710

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.3

106.5

876

3950

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.6

106.5

359

1012

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

106.4

4154

29403

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

8.9

106.4

132

149

M04AA01

ATC

allopurinol; systemic

1.6

106.4

2884

18886

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

6.1

106.1

185

306

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

106.1

1997

11927

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

105.6

20117

180980

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

8.6

105.4

134

156

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

59.1

105.2

M79.7

ICD-10 Finland

Fibromyalgia

2.1

105.2

1076

5285

132

Kela drug reimbursment

Sarcoidosis

4.8

105.1

240

507

R03AC02

ATC

salbutamol; inhalant

1.3

105.0

15840

138126

D05AX05

ATC

tazarotene; topical

11.5

104.7

108

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

103.6

3549

24457

JFH11

NOMESCO Finland

Laparoscopic colectomy

18.1

103.4

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.2

103.4

213

412

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

103.3

21337

193745

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

10.4

103.1

114

110

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

103.0

1110

5557

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.4

102.9

729

3083

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

6.1

102.3

178

294

ZXA10

NOMESCO Finland

Bilateral

1.4

102.3

4633

33711

RS222, ,

NOMESCO Finland

3.4

102.0

376

1123

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

102.0

1114

5604

R60.0

ICD-10 Finland

Localized oedema

1.5

101.9

3287

22359

5551A

ICD-9 Finland

Regional enteritis, Large intestine

23.6

101.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

101.8

916

4284

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

101.7

6555

50654

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

9.7

101.6

118

122

SPAT1263

SPAT

Sampling

1.3

101.2

11359

95112

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

101.1

574

2186

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

101.0

463

1574

M25.4

ICD-10 Finland

Effusion of joint

3.0

100.9

457

1543

A07AA09

ATC

vancomycin; oral

3.1

100.7

437

1440

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

100.3

1562

8830

J01DA01

ATC

[U] cefalexin

1.3

100.2

17201

152081

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

100.1

1781

10467

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

99.7

937

4456

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

99.5

2563

16571

A11CC03

ATC

alfacalcidol; systemic

2.5

99.5

660

2709

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

99.4

1973

11946

M49.5*C90.0

ICD-10 Finland

Vertebral fracture due to multiple myeloma

51.9

99.2

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

98.8

2333

14771

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

98.5

8146

65314

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

8.1

98.5

132

164

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

4.9

98.3

215

438

ND2BG

NOMESCO Finland

MRI of hand

6.5

98.3

160

247

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

10.6

98.3

107

101

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

98.3

411

1326

K07.60

ICD-10 Finland

Snapping jaw

1.8

98.1

1518

8562

9289

FHL

Other measure in this category

14.8

97.9

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

97.3

854

3954

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

19.8

97.3

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.9

96.9

286

736

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.5

96.8

641

2629

L11

ICPC

Wrist symptom/complaint

1.6

96.6

2657

17436

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.6

96.5

568

2202

R06AE07

ATC

cetirizine; oral

1.3

96.5

12527

106696

R2110

NOMESCO Finland

Giving the first information

1.7

96.1

1851

11114

NC1AE

NOMESCO Finland

Elbow ultrasound examination

9.8

96.1

111

114

RJ512, ,

NOMESCO Finland

10.5

95.9

105

100

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

95.8

7953

63750

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

9.2

95.4

115

125

398

Kela drug reimbursment

Ixazomib

474.0

95.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

95.3

1538

8784

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

9.8

94.0

108

110

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

16.0

93.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

93.9

3218

22148

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

93.7

1755

10457

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.9

93.5

433

1481

L12

ICPC

Hand/finger symptom/complaint

1.4

93.4

4884

36389

RS121, ,

NOMESCO Finland

4.4

93.3

232

525

JFB20

NOMESCO Finland

Ileocaecal resection

5.0

93.3

199

397

J01FA10

ATC

azithromycin; systemic

1.3

92.9

16681

147647

Z71.8

ICD-10 Finland

Other specified counselling

1.3

92.9

9780

80938

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

92.7

2020

12527

RF410, ,

NOMESCO Finland

3.2

92.6

372

1172

NHG20

NOMESCO Finland

Fusion of talocrural joint

4.4

92.5

235

541

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

92.4

6823

53711

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

92.4

5912

45528

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.7

92.3

498

1848

R5120

NOMESCO Finland

Preparation of an aid

2.3

91.7

728

3234

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.3

91.7

680

2934

JN4AD

NOMESCO Finland

Body CT examination

1.5

91.5

2932

19889

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

91.5

649

2746

A01

ICPC

Pain general/multiple sites

1.5

91.4

2726

18207

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

5.6

91.4

173

310

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

91.2

7276

57917

RT350, ,

NOMESCO Finland

10.8

91.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

90.8

1219

6576

Z01.2

ICD-10 Finland

Dental examination

1.3

90.4

13727

118877

1505

Kela drug reimbursment

Ixazomib

448.8

90.2

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.3

89.8

678

2949

A07AA02

ATC

nystatin; oral

1.8

89.7

1468

8415

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.6

89.7

293

809

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

6.0

89.7

157

261

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

14.6

89.3

WW409

NOMESCO Finland

Other aferesis

7.2

89.2

132

184

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.9

88.9

1095

5741

9283

FHL

Subtalar joint ossification surgery (or triple)

12.7

88.6

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

12.7

88.6

RD210, ,

NOMESCO Finland

2.6

88.4

539

2126

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

8.1

88.0

117

144

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

4.6

87.6

209

458

M32

ICD-10 Finland

Systemic lupus erythematosus

10.8

87.5

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

87.5

1238

6790

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

9.4

87.5

104

111

RT231, ,

NOMESCO Finland

20.6

87.2

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

5.2

87.2

180

349

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.5

87.0

303

873

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

8.3

86.9

114

138

K83.0

ICD-10 Finland

Cholangitis

2.9

86.7

415

1446

D06BB04

ATC

podophyllotoxin; topical

1.8

86.6

1358

7686

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

3.3

86.4

335

1033

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

12.3

86.1

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

6.8

85.5

134

199

RJ420, ,

NOMESCO Finland

5.6

85.2

161

288

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

21.7

85.0

QDH05

NOMESCO Finland

Correction of deformity of toe nail

6.1

84.9

148

245

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

7.6

84.9

119

156

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

12.0

84.6

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

45.5

84.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

84.5

1265

7060

RF120, ,

NOMESCO Finland

3.1

83.8

346

1108

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

83.7

3650

49522

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.0

83.3

239

603

L01EX09

ATC

nintedanib; oral

7.4

83.0

120

163

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

82.9

1381

7956

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

7.7

82.9

115

149

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

82.1

939

4798

J02AC01

ATC

fluconazole; systemic

1.3

82.1

10987

93335

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.6

82.0

196

430

L01XE31

ATC

[U] nintedanib

10.6

81.8

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

81.6

3196

22550

D09AB01

ATC

zinc bandage without supplements; topical

2.5

81.3

528

2146

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.4

81.3

582

2473

M05.2

ICD-10 Finland

Rheumatoid vasculitis

21.1

81.2

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

5.6

81.1

152

270

RF420, ,

NOMESCO Finland

2.8

80.9

400

1418

R3130

NOMESCO Finland

Training in activities of daily lining

24.8

80.9

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.3

80.6

313

966

I77.6

ICD-10 Finland

Arteritis, unspecified

7.5

79.7

114

153

9531

FHL

Arthrodesis of the hand joint

5.9

79.3

141

238

K02.1

ICD-10 Finland

Caries of dentine

1.3

79.3

17248

154762

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.3

79.3

158

297

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

79.2

439

1652

R5110, ,

SPAT

1.6

79.2

2171

14210

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

79.2

1097

5975

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.2

79.1

668

3044

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.7

79.0

255

699

5AB14, ,

NOMESCO Finland

8.2

78.8

104

127

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

78.6

683

3149

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

78.5

2954

20671

9260

FHL

Alloarthroplasty, endoprosthesis or implant

22.8

78.4

S01FA04

ATC

cyclopentolate; ophthalmic

3.2

78.4

311

973

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

4.1

78.2

218

539

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

78.0

938

4876

ACC51

NOMESCO Finland

Release of median nerve

1.6

77.8

1994

12851

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

12.2

77.6

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

18.3

77.5

AA1AA

NOMESCO Finland

Head X-ray examination

3.7

77.3

246

668

L84

ICD-10 Finland

Corns and callosities

2.0

77.2

924

4796

395

Kela drug reimbursment

Dupilumab

6.3

77.1

129

205

Z85.6

ICD-10 Finland

Personal history of leukaemia

19.4

77.1

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

77.0

2332

15601

A03

ICPC

Fever

1.4

76.5

4838

37053

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

76.5

834

4191

D11AH01

ATC

tacrolimus; topical

3.1

76.4

325

1060

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.8

76.3

1313

7632

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

12.6

75.8

WW400

NOMESCO Finland

Plasmaferesis

7.7

75.7

105

136

602

Kela drug reimbursment

Children's severe malnutrition

6.0

75.6

132

219

RJ412, ,

NOMESCO Finland

8.0

75.5

102

128

TK800

NOMESCO Finland

Hemodialysis

2.3

75.4

558

2406

N02BF01

ATC

gabapentin; oral

1.5

75.1

2791

19475

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.4

74.9

188

429

Z94.1

ICD-10 Finland

Heart transplant status

6.8

74.9

116

170

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.9

74.8

937

4938

L26

ICD-10 Finland

Exfoliative dermatitis

7.4

74.6

108

147

M31.6

ICD-10 Finland

Other giant cell arteritis

6.1

74.2

129

213

D11AH05

ATC

dupilumab; topical

5.9

74.2

132

223

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

74.0

9335

78473

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

74.0

627

2861

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

13.5

73.9

H15.1

ICD-10 Finland

Episcleritis

2.5

73.9

459

1827

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.1

73.5

312

1016

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.4

73.3

498

2067

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.0

73.2

210

530

S01XA18

ATC

ciclosporin; ophthalmic

3.4

73.2

269

803

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

5.1

73.0

152

297

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

17.2

72.9

R05

ICD-10 Finland

Cough

1.3

72.8

5794

45870

M60.9

ICD-10 Finland

Myositis, unspecified

4.1

72.7

198

481

K60.3

ICD-10 Finland

Anal fistula

2.4

72.7

487

2009

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

9.0

72.6

D11AH04

ATC

alitretinoin; oral

9.7

72.3

D07AA02

ATC

hydrocortisone; topical

1.4

72.2

3600

26499

A28

ICPC

Limited function/disability NOS

1.4

72.1

3893

29042

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

4.6

72.1

172

377

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

71.9

6744

54586

R4190

NOMESCO Finland

Nutritional therapy

1.8

71.8

1126

6370

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.5

71.7

176

395

RJ190, ,

NOMESCO Finland

7.0

71.5

108

154

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

15.0

71.5

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.0

71.4

320

1075

L40.1

ICD-10 Finland

Generalized pustular psoriasis

13.4

71.4

Z93.2

ICD-10 Finland

Ileostomy status

5.0

71.2

151

300

SPAT1301

SPAT

No procedures

1.3

71.1

7921

65523

3060, ,

Kela drug reimbursment

88.0

70.9

M02AA07

ATC

piroxicam; topical

1.3

70.9

8893

74621

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.4

70.8

484

2015

B05DA

ATC

Isotonic solutions

3.6

70.7

230

634

L03AB08

ATC

interferon beta-1b; parenteral

6.0

70.7

125

210

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

70.6

1644

10346

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.4

70.6

138

255

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

70.1

1451

8865

1534, ,

Kela drug reimbursment

86.9

69.9

H15.0

ICD-10 Finland

Scleritis

4.8

69.8

158

332

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

69.7

4296

32720

SFA10

NOMESCO Finland

One-surface restoration

1.2

69.7

15850

141969

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

6.4

69.4

115

181

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.4

69.3

472

1961

RT172, ,

NOMESCO Finland

9.4

69.3

RT160, ,

NOMESCO Finland

8.7

69.2

100

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

18.3

68.9

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

68.9

1335

8015

Z22.30

ICD-10 Finland

Latent tuberculosis

14.0

68.8

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

6.7

68.7

108

161

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

68.6

5061

39591

1370

FHL

Colonoscopy, whole colon

4.7

68.6

157

333

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

68.3

474

1987

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.0

68.2

742

3725

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

68.0

1206

7068

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

4.6

68.0

162

355

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

67.8

633

3002

Z94.2

ICD-10 Finland

Lung transplant status

7.1

67.8

101

142

TEG00

NOMESCO Finland

Punction of mandibular joint

8.6

67.8

100

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

67.6

21264

196848

Z50.1

ICD-10 Finland

Other physical therapy

1.7

67.5

1283

7662

WZA00

NOMESCO Finland

Concise certificate

1.6

67.3

1710

10989

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

67.2

10138

86762

6BA02, ,

NOMESCO Finland

5.4

67.0

131

242

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

67.0

6728

54859

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

28.1

66.6

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.9

66.6

309

1059

N02BF02

ATC

pregabalin; oral

1.6

66.6

1806

11779

M06.2

ICD-10 Finland

Rheumatoid bursitis

24.8

66.6

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

66.3

1357

8265

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.1

66.1

272

870

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.6

66.0

385

1487

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

66.0

697

3462

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

5.1

65.8

137

268

NDG71

NOMESCO Finland

Arthrodes of first MP joint

5.3

65.7

132

250

L04AA31

ATC

[U] teriflunomide

5.5

65.6

126

229

M15.3

ICD-10 Finland

Secondary multiple arthrosis

5.2

65.4

135

262

RT274, ,

NOMESCO Finland

7.2

65.3

133

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

64.6

5625

44983

V03AG01

ATC

sodium cellulose phosphate; systemic

9.5

64.6

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

64.6

4411

34088

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

64.5

1475

9237

L16

ICPC

Ankle symptom/complaint

1.4

64.5

3198

23490

J04BA02

ATC

dapsone; oral

4.0

64.4

186

472

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

64.3

2203

15106

JHA00

NOMESCO Finland

Anal or perianal incision

2.5

64.1

395

1567

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.7

63.9

1139

6682

H26.2

ICD-10 Finland

Complicated cataract

2.7

63.9

350

1310

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

63.8

651

3193

H57.1

ICD-10 Finland

Ocular pain

1.8

63.8

1073

6193

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

63.7

2869

20720

A02BB01

ATC

misoprostol; oral

4.1

63.7

173

420

RF212, ,

NOMESCO Finland

5.1

63.7

133

261

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.2

63.5

559

2591

L30.3

ICD-10 Finland

Infective dermatitis

1.8

63.5

904

4965

M02.3

ICD-10 Finland

Reiter disease

8.2

63.4

103

L04AA05

ATC

[U] tacrolimus

10.2

63.3

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

6.7

63.2

147

ZX100

NOMESCO Finland

Oral

2.6

63.1

358

1364

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

63.0

731

3754

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

21.4

62.9

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

2.0

62.5

663

3298

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

62.4

719

3683

TFJ02

NOMESCO Finland

Muscle biopsy of heart

6.4

62.3

103

162

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

62.2

916

5083

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.4

62.1

424

1765

0108, ,

NOMESCO Finland

24.5

62.0

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

9.5

62.0

C08CA01

ATC

amlodipine; oral

1.2

61.8

9293

79311

N06AX21

ATC

duloxetine; oral

1.4

61.7

3132

23085

R11

ICD-10 Finland

Nausea and vomiting

1.5

61.7

2200

15202

M11.2

ICD-10 Finland

Other chondrocalcinosis

4.9

61.6

135

276

4AA09, ,

NOMESCO Finland

22.5

61.5

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

61.4

5321

42491

SFA20

NOMESCO Finland

Two-surface restoration

1.2

61.1

16821

152677

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

60.9

708

3639

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

60.8

2893

21083

D05AC01

ATC

dithranol; topical

10.8

60.6

M01AB01

ATC

indometacin; systemic, rectal

1.6

60.5

1504

9610

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.5

60.4

145

320

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

60.3

861

4732

M54.5

ICD-10 Finland

Low back pain

1.2

60.2

10084

87005

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.2

60.1

161

387

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

60.0

1552

10007

C07AB07

ATC

bisoprolol; oral

1.2

59.7

11842

103947

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

59.7

3520

26576

R05

ICPC

Cough

1.3

59.5

6745

55685

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.4

59.5

217

645

M35.2

ICD-10 Finland

Behçet disease

14.2

59.5

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

11.3

59.4

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.6

59.4

345

1331

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.9

59.3

285

996

M01AB08

ATC

etodolac; oral

1.5

59.3

1715

11340

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

4.5

59.2

143

317

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

10.2

58.9

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

58.8

776

4161

L04AG12

ATC

ofatumumab; parenteral

9.3

58.7

RJ210, ,

NOMESCO Finland

5.8

58.7

106

182

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

58.6

2354

16636

M94.1

ICD-10 Finland

Relapsing polychondritis

14.3

58.6

ZXC50

NOMESCO Finland

Cryotherapy

2.0

58.5

676

3467

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

58.4

582

2830

M48.0

ICD-10 Finland

Spinal stenosis

1.4

58.3

2775

20221

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

17.2

58.2

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

58.2

1757

11725

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

58.2

1631

10710

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

23.3

58.2

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

23.3

58.2

XQ802

NOMESCO Finland

Epicutan test

1.7

58.1

1044

6139

I73.0

ICD-10 Finland

Raynaud syndrome

2.2

58.0

486

2209

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

57.8

2460

17570

L01XG03

ATC

ixazomib; oral

568.8

57.6

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.6

57.5

190

530

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.0

57.4

250

827

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

6.6

57.4

140

N06AA09

ATC

amitriptyline; systemic

1.5

57.4

2205

15451

ZX114

NOMESCO Finland

Intramuscular

2.4

57.3

402

1694

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

12.5

57.1

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

5.4

56.9

111

205

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.3

56.9

418

1798

WW500

NOMESCO Finland

Blood transfusion

1.8

56.8

940

5400

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

56.6

1243

7704

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

56.6

949

5473

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

56.5

785

4278

212

Kela drug reimbursment

Gout

2.4

56.4

392

1645

GDG10

NOMESCO Finland

Bilateral transplantation of lung

7.7

56.3

101

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

56.2

5055

40510

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

56.2

3431

26028

M31.0

ICD-10 Finland

Hypersensitivity angiitis

15.3

56.1

SFA30

NOMESCO Finland

Three-surface restoration

1.2

56.0

11538

101451

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

56.0

1137

6908

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

4.9

55.8

122

249

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.4

55.8

404

1726

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

6.5

55.8

141

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

55.8

839

4685

UJF02

NOMESCO Finland

Peroral enteroscopy

3.5

55.8

189

536

L28.1

ICD-10 Finland

Prurigo nodularis

3.2

55.8

219

682

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

55.7

2975

22090

M02.1

ICD-10 Finland

Postdysenteric arthropathy

5.1

55.5

116

228

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

55.4

15580

141083

L03AA02

ATC

filgrastim; parenteral

1.9

55.3

717

3823

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

7.9

55.1

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

3.7

55.1

174

471

M05.1

ICD-10 Finland

Rheumatoid lung disease

24.4

54.9

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

5.8

54.8

170

7143X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]

20.0

54.6

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

54.6

350

1416

L15

ICPC

Knee symptom/complaint

1.3

54.6

6695

55696

B74

ICPC

Malignant neoplasm blood other

6.3

54.3

145

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

54.3

1440

9335

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

8.7

54.2

SAA04

NOMESCO Finland

Special examination of mouth

1.6

54.1

1330

8471

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

4.1

54.1

150

370

L57.0

ICD-10 Finland

Actinic keratosis

1.4

54.1

2281

16258

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.0

54.0

571

2838

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

53.6

1643

10995

A98

ICPC

Health maint/preventive medicine

1.6

53.5

30078

293767

NH1DG

NOMESCO Finland

Ankle and foot very extensive MRI examination with high intensity magnet

5.3

53.4

106

199

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

53.2

7030

58947

NDG20

NOMESCO Finland

Fusion of wrist, partial

3.6

53.2

175

487

135

Kela drug reimbursment

Pemphigus

21.1

53.1

M03BX02

ATC

tizanidine; oral

1.2

53.1

17574

161267

D05AX

ATC

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015377) Calcium [Moles/volume] in Serum or Plasma

12806

95185

1.58

316.44

3.6

3.5

2.35

2.36

mmol/l

22.24

11963

86812

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

763

1691

4.60

315.00

2.6

435.44

541.01

e6/l

6.27

597

1349

(3017354) Segmented neutrophils/Leukocytes in Blood

950

2500

3.88

312.24

3.5

3.4

57.56

57.19

0.21

839

2145

(3008757) Leukocyte morphology finding [Identifier] in Blood

908

2316

4.00

311.77

3.8

3.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1500

5262

2.94

311.37

1.8

1.5

142.02

148.29

au/ml

0.92

379

1559

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5139

30164

1.84

309.28

2.2

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2047

8452

2.52

308.86

2.8

2.6

—

(3010503) CD19 cells [#/volume] in Blood

673

1367

5.00

308.60

2.2

2.8

146.59

360.14

e6/l

1.65

654

1330

(3018333) Ribosomal P Ab [Presence] in Serum

1083

1899

5.87

307.65

1.3

1.1

—

(3001604) Monocytes [#/volume] in Blood

28998

137601

16.10

307.65

18.5

4.9

0.58

e9/l

4.66

27580

117182

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1825

5853

3.25

307.65

1.5

1.3

29.97

49.95

u/ml

1.67

(40761535) Cells panel - Urine sediment

3871

18983

2.18

307.65

5.9

3.1

0.80

1.55

—

(3007164) IgA [Mass/volume] in Serum or Plasma

10172

58714

2.08

307.65

2.2

1.4

2.50

2.33

g/l

9.78

7305

36140

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2121

7285

3.05

307.65

5.0

1.8

0.03

0.02

g/l

0.38

1887

6604

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

397

45.13

307.65

1.8

1.7

1.67

1.83

mg/l

0.57

339

(3006571) Granulocytes/Leukocytes in Synovial fluid

2069

2175

10.11

307.65

1.9

1.4

50.75

59.99

12.92

1420

1273

(40758558) Short blood count panel - Blood

14304

82756

2.34

307.65

12.4

5.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3227

7920

4.42

307.65

2.7

1.5

0.22

0.24

g/l

23.57

3108

7552

(3001122) Ferritin [Mass/volume] in Serum or Plasma

17658

136803

1.66

307.65

4.0

3.1

135.88

116.85

ug/l

14.49

16849

128483

(3017143) Hepatitis C virus Ab [Presence] in Serum

9287

32127

3.69

307.65

1.5

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1474

3171

4.82

307.65

1.4

1.2

48.85

58.91

u/ml

0.64

110

171

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1649

5717

2.99

307.65

1.7

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1413

294

50.24

307.65

2.2

2.1

9.01

9.26

mg/l

0.33

1166

245

(3026782) Osmolality of Urine

7968

50784

1.76

307.65

3.9

2.8

524.98

531.00

mosm/kgh2o

1.67

7269

44353

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

895

1117

8.21

307.65

1.2

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12247

69992

2.23

307.65

3.2

2.3

2.91

2.74

mg/l

14.54

11137

60469

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1887

6447

3.05

307.65

2.0

1.5

—

(3011412) CD3 cells [#/volume] in Blood

1090

2345

4.78

307.65

2.4

2.5

1102.49

1223.74

e6/l

3.30

946

2041

(36304419) Bacteria [Presence] in Urine

11658

72345

1.97

307.65

4.3

3.1

263.64

117.16

estimate

0.24

278

(3013650) Neutrophils [#/volume] in Blood by Automated count

29205

155257

14.20

307.65

22.2

8.4

3.93

4.09

e9/l

42.16

27870

133289

(3030467) Casts [#/volume] in Urine by Automated count

12135

75910

1.98

307.65

4.5

3.2

0.31

0.41

e6/l

6.42

9767

54338

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12794

46839

3.93

307.65

1.5

1.3

42.29

3.77

u/ml

177.93

5540

18138

(3023368) Bacteria identified in Blood by Culture

11429

71477

1.94

307.65

5.4

4.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2351

8566

2.88

307.65

5.4

1.7

10.18

10.10

g/l

0.29

2174

7633

(3037522) Nuclear Ab [Titer] in Serum

13203

36941

5.45

307.65

1.6

1.3

607.46

501.13

titre

7.30

3641

7053

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5484

31985

1.86

307.65

2.2

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

7474

19648

4.68

307.65

5.0

2.3

10.61

10.50

g/l

1.01

7139

18097

(3042936) Bacteria identified in Isolate by Culture

7056

38097

2.10

307.65

2.4

2.0

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

28996

202932

6.83

307.65

12.6

3.6

13.46

11.28

mm/h

123.30

28520

190127

(3009261) Glucose [Presence] in Urine by Test strip

23277

147619

3.25

307.65

6.2

3.6

0.01

0.22

estimate

2.09

5885

27854

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2800

9884

3.01

307.65

5.4

1.7

3.72

3.70

g/l

0.21

2650

9039

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1366

4280

3.29

307.65

2.1

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7702

39427

2.26

307.65

3.1

2.6

22.34

22.89

2.96

7326

36666

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2986

7358

4.38

307.65

1.4

1.3

5.36

5.76

u/ml

0.10

407

603

(3025159) Blasts/Leukocytes in Blood

8053

21332

4.73

307.65

8.3

3.8

0.16

0.36

1.87

2185

5332

(3047189) Immunofixation for 24 hour Urine

553

878

6.39

307.65

2.8

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

11608

66242

2.19

307.65

6.1

3.5

0.52

0.30

0.75

614

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3894

19893

2.09

307.65

2.4

22.37

21.29

au/ml

0.32

350

2332

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

841

1866

4.60

307.65

2.3

2.1

14.93

14.57

0.36

819

1821

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1084

203

55.23

307.65

1.8

1.6

118.17

179.73

au/ml

0.75

154

(21494890) Protein electrophoresis panel - 24 hour Urine

995

2183

4.67

307.65

3.8

1.6

—

(21494815) CD4 cells/Lymphocytes in Specimen

928

2195

4.32

307.65

2.2

2.3

43.13

37.87

17.10

914

2162

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3261

8183

4.33

307.65

2.7

1.5

1.17

1.20

g/l

4.41

3152

7832

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2985

7334

4.39

307.65

1.4

1.3

13.44

6.12

u/ml

5.17

609

934

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19124

145129

1.81

307.65

8.2

6.5

10.33

11.32

umol/l

32.91

18490

138118

(3010144) Erythrocytes [#/volume] in Synovial fluid

1349

1801

7.78

307.65

1.8

1.2

43110.43

159552.16

e6/l

6.96

925

1157

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1101

1960

5.78

307.65

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5169

20613

2.80

307.65

5.8

2.1

66.23

66.52

g/l

1.81

4895

18944

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30382

271328

5.10

307.65

32.3

14.2

17.38

23.90

mg/l

307.65

28371

219968

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4072

21443

2.03

307.65

2.9

2.4

0.25

0.42

e6/l

9.47

3844

20492

(3029937) Albumin [Presence] in Urine by Test strip

13638

78608

2.30

307.65

6.6

3.8

0.00

0.01

estimate

0.81

5876

26652

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10605

44559

3.08

307.65

1.6

1.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1040

2780

3.83

307.65

1.6

1.3

2.84

2.93

g/l

0.69

755

2022

(3031040) Bacteria [#/volume] in Urine by Automated count

21727

179717

1.68

307.65

6.0

4.5

1419.55

1793.98

e6/l

0.31

237

2433

(3009871) Measles virus Ab [Titer] in Serum

667

844

8.05

307.65

1.6

3246.13

3737.21

titre

0.61

124

122

(3027135) IgG subclass 1 [Mass/volume] in Serum

1041

2782

3.83

307.65

1.6

1.3

6.98

6.65

g/l

1.43

757

2024

(3026493) Urate [Moles/volume] in Serum or Plasma

12915

70592

2.41

307.65

3.5

2.6

321.77

338.44

umol/l

71.29

11929

62554

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1442

4841

3.07

307.65

1.7

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1740

5480

3.30

307.65

1.5

1.3

285.59

256.01

u/ml

3.00

1036

3537

(3024561) Albumin [Mass/volume] in Serum or Plasma

18763

121448

2.36

307.65

8.6

4.8

35.75

36.05

g/l

11.77

18080

113898

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1560

3902

4.15

307.65

2.2

1.3

10.73

16.20

u/ml

1.15

(3027945) Reticulocytes/Erythrocytes in Blood

6168

29095

2.39

307.65

3.6

2.6

1.81

1.77

1.91

5725

25976

(3018418) pH of Serum or Plasma

13327

80733

2.13

307.65

6.5

4.1

7.40

0.94

9970

57040

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

680

403

17.21

307.65

1.8

1.5

9.01

9.64

ug/l

1.40

680

403

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1830

6571

2.89

307.65

5.3

1.8

0.00

g/l

-0.00

1736

6158

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2337

6723

3.67

307.65

1.2

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1582

3554

4.63

307.65

1.3

1.2

29.65

11.83

u/ml

2.60

134

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11755

83359

1.65

307.65

2.8

2.2

152.71

206.37

u/l

14.08

11301

78828

(3018095) Leukocytes [#/volume] in Urine

16183

101163

2.24

307.65

5.8

3.8

70.31

90.62

e6/l

2.56

11736

69948

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4737

18747

2.80

307.65

2.1

1.6

—

(3013115) Eosinophils [#/volume] in Blood

29092

142605

15.79

307.65

19.0

5.1

0.18

0.19

e9/l

42.77

27876

123576

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

29314

208458

7.42

307.65

17.4

7.5

73.98

79.10

u/l

118.92

29047

197837

(3021589) Normoblasts [#/volume] in Blood

21316

122107

3.33

307.65

23.6

10.0

0.00

e9/l

4.69

19305

98189

(3022948) Iron [Moles/volume] in Serum or Plasma

8676

46323

2.21

307.65

3.1

2.6

12.80

13.88

umol/l

1.81

8287

43272

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

909

1785

5.21

307.65

2.8

1.5

3.77

3.68

mg/l

0.24

876

1714

(3014148) Varicella zoster virus Ab [Titer] in Serum

1559

3547

4.57

307.65

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2854

6203

4.96

307.65

1.4

1.2

24.18

9.23

u/ml

1.50

(3022096) Basophils/Leukocytes in Blood

26384

126478

7.92

307.65

19.1

5.1

0.75

0.68

114.76

26036

118144

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

29089

260156

2.67

307.65

26.5

14.0

85.82

83.32

ml/min/173m2

80.25

27971

238798

(3023420) DNA double strand Ab [Units/volume] in Serum

5816

9767

7.08

307.65

2.4

1.6

10.07

6.45

iu/ml

3.59

1582

2154

(3021440) Promyelocytes/Leukocytes in Blood

8060

20977

4.82

307.65

7.8

3.7

0.08

0.13

7.98

2230

5515

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

924

2186

4.32

307.65

1.3

1.2

82.41

65.76

u/ml

0.62

(3010375) cycloSPORINE [Mass/volume] in Blood

687

916

7.64

307.65

29.1

31.6

118.53

118.54

ug/l

0.00

590

739

(3024980) IgG subclass 4 [Mass/volume] in Serum

1618

4506

3.73

307.65

2.0

1.5

0.75

g/l

0.02

1257

3541

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12945

95923

1.59

307.65

4.7

3.3

33.44

33.07

u/l

0.22

12288

90731

(3019198) Lymphocytes [#/volume] in Blood

29036

141120

15.66

307.65

18.7

4.9

1.81

1.95

e9/l

67.04

27850

123309

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1278

275

48.37

307.65

2.8

3.1

156.88

121.17

au/ml

0.83

187

(3038026) Centromere Ab [Units/volume] in Serum

833

1846

4.60

307.65

1.3

1.2

57.10

50.61

u/ml

0.23

116

(3045424) Erythrocytes [Presence] in Urine

3695

12408

3.24

307.65

2.5

2.0

0.01

0.17

estimate

1.07

1392

3854

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

7432

5359

17.86

307.65

1.6

1.5

3.16

7.86

iu/ml

0.56

1338

962

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2155

7138

3.17

307.65

2.8

2.0

11.24

11.35

mg/l

0.24

2029

6704

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3005

8913

3.62

307.65

1.3

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

831

1688

5.03

307.65

1.8

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1632

5675

2.98

307.65

1.7

1.4

29.80

20.56

u/ml

1.20

111

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3933

5216

8.47

307.65

1.8

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2259

9425

2.50

307.65

1.5

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7783

47808

1.83

307.65

3.7

2.9

0.86

1.18

e6/l

4.60

4867

24476

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8110

43144

2.19

307.65

3.1

2.6

2.31

2.36

g/l

12.31

7677

39888

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16314

110538

1.99

307.65

6.1

3.5

0.13

0.54

estimate

2.53

5343

23414

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6074

30050

2.27

307.65

4.9

4.5

241.80

242.17

u/l

0.06

5835

28590

(3008898) HLA-B27 [Presence]

3607

9161

4.32

307.65

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1162

2119

5.65

307.65

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3198

9124

3.79

307.65

1.6

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

3546

5045

7.79

307.65

2.1

1.4

8848.77

15237.63

e6/l

11.81

2729

3424

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1545

1630

9.91

307.65

1.9

1.3

38.39

27.33

16.52

1026

931

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7238

43331

1.87

307.65

2.4

1.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1606

4494

3.71

307.65

1.5

1.2

420.30

182.88

titre

4.55

201

271

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17868

121716

2.09

307.65

10.1

6.5

1.22

1.21

mmol/l

9.34

17120

112822

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

12876

51392

3.55

307.65

1.5

1.3

70.95

24.38

iu/ml

50.53

5417

14467

(3045414) Leukocytes [Presence] in Urine

5682

25329

2.52

307.65

2.4

2.0

0.01

0.03

estimate

3.66

1519

4995

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2490

7951

3.31

307.65

9.6

2.1

53.95

39.60

mg/l

1.71

2126

6765

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

796

1735

4.68

307.65

2.7

199.34

236.38

e6/l

2.98

665

1452

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2801

9901

3.01

307.65

5.4

1.7

4.23

g/l

0.08

2652

9059

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

2247

6014

3.94

307.65

1.4

1.2

54.00

39.26

u/ml

3.31

314

472

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

328

126

26.27

307.65

3.5

2.4

—

(3035350) Ketones [Presence] in Urine by Test strip

23215

146464

3.26

307.65

6.1

3.6

6.20

3.75

estimate

1.25

6135

29358

(3017732) Neutrophils [#/volume] in Blood

10216

32528

4.17

307.65

4.1

2.9

4.12

4.55

e9/l

5.95

9254

28121

(3015171) Extractable nuclear Ab [Units/volume] in Serum

4202

9956

4.72

307.65

1.4

1.2

1.18

0.76

u/ml

1.18

337

782

(40768443) Skin Pathology biopsy report

2684

12244

2.30

307.65

1.4

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1666

5874

2.94

307.65

1.7

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

716

1215

6.00

307.65

1.2

1.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

8182

20784

4.97

307.65

7.1

3.6

0.44

0.80

32.53

2463

6153

(3021601) Nitrite [Presence] in Urine by Test strip

23128

144707

3.29

307.65

6.1

3.6

0.00

estimate

2.36

6047

28746

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2607

1696

16.66

307.65

1.1

1.42

2.26

iu/ml

1.27

(46235355) HIV 1 and 2 tests - Meaningful Use set

10365

53833

2.38

307.65

1.8

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2728

11431

2.52

307.65

1.9

1.8

1.55

1.52

g/l

0.70

2375

9856

(3000850) Epithelial cells [#/volume] in Urine

10551

59322

2.17

307.65

3.7

2.6

4.73

5.98

e6/l

14.85

9906

53737

(3023520) Reticulocytes [#/volume] in Blood

4996

22212

2.48

307.65

2.9

2.7

69.56

70.13

e9/l

0.49

3679

16114

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2263

7011

3.40

307.65

9.1

2.0

9.36

2.72

ratio

3.13

1365

3948

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1149

2067

5.73

307.65

1.3

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1684

4264

4.11

307.65

4.7

2.8

2893.79

5803.67

u/ml

0.43

125

221

(3007566) Smooth muscle Ab [Titer] in Serum

2180

7981

2.86

307.65

1.5

1.2

169.48

108.09

titre

1.45

231

749

(3032080) INR in Blood by Coagulation assay

15770

122177

1.58

307.65

13.7

13.4

1.19

1.22

inr

11.63

13318

101517

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1110

1964

5.82

307.65

1.3

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

357

141

25.58

307.65

3.5

2.4

23.80

26.23

mg/l

1.01

337

135

(3002030) Lymphocytes/Leukocytes in Blood

26641

130390

8.01

307.65

18.7

5.0

27.78

28.41

21.23

26338

123409

(3006315) Basophils [#/volume] in Blood

29022

137950

16.21

307.65

18.6

4.9

0.04

e9/l

2.55

27592

117431

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2659

6069

4.69

307.65

1.4

1.2

3.87

5.83

u/ml

0.64

232

361

(3034860) Kappa light chains.free [Mass/volume] in Serum

2487

7969

3.30

307.65

9.6

2.1

54.31

61.89

mg/l

0.37

2124

6783

(3036071) Salmonella sp Ab [Titer] in Serum

507

670

7.67

307.65

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

11900

79762

1.79

307.65

5.0

3.1

0.11

0.27

estimate

1.26

5329

22905

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

356

147

24.46

307.65

1.1

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5363

26728

2.21

307.65

2.4

2.3

339.84

382.01

nmol/l

44.96

5087

24856

(3037467) Urinalysis macro (dipstick) panel - Urine

26380

186056

3.66

307.65

8.3

4.2

2.29

4.34

0.54

270

(3024263) Appearance of Synovial fluid

610

1000

6.20

307.65

2.7

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

3092

7946

4.20

307.65

1.4

1.2

40.03

39.38

u/ml

0.04

205

393

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3745

10589

3.88

307.65

2.7

1.3

18.51

7.86

iu/ml

5.83

282

150

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1937

6666

3.03

307.65

2.1

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

10871

75894

1.66

307.65

1.9

1.7

20.45

20.24

nmol/l

0.56

9538

64862

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1130

2042

5.70

307.65

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1300

2364

5.69

307.65

1.3

1.2

—

(1175426) CD3 cells/Lymphocytes in Blood

876

1939

4.61

307.65

2.4

2.1

73.64

72.36

1.40

840

1871

(3037756) Immunofixation for Serum or Plasma

1785

4571

4.08

307.65

3.0

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3068

11386

2.88

307.65

2.8

1.9

37.66

40.19

u/l

9.44

2833

10164

(3022145) Colonoscopy Study observation

6618

31592

2.39

307.65

1.9

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

8411

21931

4.87

307.65

7.6

3.7

0.70

1.01

20.00

2582

6438

(4062490) Immunoglobulin typing, IgG

1023

2734

3.83

307.65

1.6

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1039

2780

3.83

307.65

1.6

1.3

0.43

0.40

g/l

0.78

754

2021

(3034770) Mitochondria Ab [Titer] in Serum

2141

7838

2.86

307.65

1.4

1.2

754.26

949.70

titre

0.61

234

(3007853) Bacteria identified in Skin by Aerobe culture

5550

32607

1.85

307.65

2.1

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3651

18340

2.12

307.65

1.3

51.79

50.84

au/ml

0.08

179

1183

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1191

2552

4.81

307.65

1.3

1.2

53.46

41.64

u/ml

0.68

125

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2015

6990

3.01

307.65

5.0

1.8

0.00

g/l

0.10

1738

6175

(3048689) Calprotectin [Mass/mass] in Stool

8611

37420

2.79

307.65

6.2

2.0

185.28

120.28

ug/g

48.61

7694

29289

(3028026) IgM [Mass/volume] in Serum or Plasma

5679

15413

4.28

307.65

2.6

1.8

1.14

1.34

g/l

11.60

5305

14230

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1129

2038

5.70

307.65

1.3

1.1

—

(3006504) Eosinophils/Leukocytes in Blood

26502

126402

8.16

307.65

18.8

5.0

2.76

2.86

14.14

26155

118200

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1592

3774

4.39

307.65

1.1

0.50

8.53

—

(3019069) Monocytes/Leukocytes in Blood

26574

126741

8.27

307.65

19.0

5.1

9.08

8.71

100.04

26224

118629

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

26267

230107

1.88

307.65

37.5

17.5

14.02

13.52

307.65

26192

227072

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

323

44.05

307.65

1.7

1.5

—

(3021788) Differential panel - Synovial fluid

2936

3703

8.64

307.65

1.8

1.4

1.00

0.94

0.48

(3004809) Band form neutrophils/Leukocytes in Blood

1457

3873

3.89

307.65

3.4

1.08

1.67

8.63

1344

3465

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2486

8522

3.08

307.65

5.6

1.8

1.18

0.65

g/l

7.30

2162

7385

(3002582) Erythrocytes [#/volume] in Urine

13617

87915

1.97

307.65

4.8

3.3

41.89

77.62

e6/l

5.28

11330

65831

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2673

9378

3.02

307.65

5.4

1.7

2.99

2.85

g/l

8.41

2522

8526

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2315

7169

3.40

307.65

2.3

1.3

12.62

16.37

iu/ml

0.70

117

113

(3018010) Neutrophils/Leukocytes in Blood

26509

127818

8.02

307.65

18.3

4.9

57.96

56.72

66.88

26253

121915

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21074

125704

3.07

307.65

3.6

2.4

77.49

792.65

nmol/l

0.50

20286

114546

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1617

4540

3.70

307.65

1.5

1.2

157.60

109.60

titre

0.55

(3000494) Fungus identified in Specimen by Culture

5804

33902

1.87

307.65

1.7

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

1241

3217

3.97

307.65

1.4

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19568

136119

2.16

307.65

11.3

7.0

1.22

1.21

mmol/l

3.61

17349

117866

(3015736) pH of Urine

19286

116813

2.69

307.65

5.2

3.2

6.27

6.21

13.07

10177

65599

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1418

326

45.47

307.65

3.6

3.8

8.34

9.24

mg/l

1.24

1149

257

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2804

9915

3.01

307.65

5.4

1.7

7.45

7.32

g/l

3.25

2653

9061

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2489

5260

5.05

307.65

6.7

5.9

474.33

1318.58

iu/ml

1.63

370

758

(3034891) Synovial lining cells/cells in Synovial fluid

880

842

10.72

307.65

1.7

1.3

4.72

3.41

1.07

223

157

(3014051) Protein [Presence] in Urine by Test strip

12220

80466

1.85

307.65

4.2

2.8

0.10

0.06

0.61

145

1688

(40761536) Microorganisms panel - Urine sediment

3942

21345

1.97

303.39

5.4

3.8

—

(3019150) Specific gravity of Urine by Refractometry

9356

65043

1.62

302.91

6.8

3.7

1.16

kg/l

0.00

7036

42039

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2228

9722

2.39

297.61

2.1

2.0

2.27

2.24

ug/l

0.02

2011

8658

(3013166) Neutrophils/Leukocytes in Synovial fluid

404

519

7.87

292.86

1.8

1.2

46.60

58.44

6.10

362

426

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

828

2086

4.05

289.05

1.4

1.2

258.42

118.00

titre

1.38

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5818

36085

1.75

288.50

9.8

6.0

1.05

1.04

mmol/l

0.13

5551

33648

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

827

2092

4.03

287.08

1.4

1.2

228.98

181.18

titre

0.88

236

255

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30512

287061

3.49

284.25

32.0

10.6

26.79

26.50

u/l

1.99

30391

279429

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10435

75453

1.57

281.37

3.9

3.0

1247.72

1192.01

ng/l

0.59

9142

64264

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30565

288480

3.53

270.53

37.8

18.4

75.76

75.37

umol/l

1.11

30480

285370

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

631

1359

4.71

269.71

1.1

1517.81

1537.82

miu/ml

0.16

631

1359

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1146

3765

3.12

266.40

1.7

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

647

1445

4.55

264.39

2.2

1.2

6.06

5.79

u/l

0.36

573

1228

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1011

3102

3.33

263.21

1.9

1.5

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

375

501

7.56

262.78

1.5

1.2

41.90

39.95

0.34

276

311

(3019309) Folate [Moles/volume] in Red Blood Cells

6445

42287

1.66

255.41

1.8

1.7

1174.64

1164.77

nmol/l

0.37

5107

32277

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1336

4945

2.78

250.18

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1443

5572

2.66

248.76

1.5

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15095

120277

1.49

248.45

2.3

2.1

93.99

97.41

pmol/l

17.30

9174

63143

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1731

7308

2.45

247.62

1.8

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1012

3234

3.20

246.33

2.0

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4428

26616

1.77

240.51

3.1

2.3

0.22

0.21

g/l

8.69

4200

24901

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1137

3941

2.95

240.36

1.8

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

939

2942

3.26

236.09

3.7

2.2

0.85

1.38

g/24h

10.61

626

1715

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

673

1691

4.04

235.60

2.4

2.7

0.64

0.70

e9/l

1.45

643

1627

(3013826) Glucose [Moles/volume] in Serum or Plasma

19191

161405

1.49

234.70

7.1

5.0

6.52

6.66

mmol/l

17.92

18446

152573

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

453

829

5.53

233.49

2.0

1.8

10408.64

32490.09

u/ml

0.79

116

(42529582) MDA5 Ab [Presence] in Serum by Line blot

380

598

6.41

228.84

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

380

598

6.41

228.84

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

380

598

6.41

228.84

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

380

598

6.41

228.84

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1350

5299

2.62

224.82

1.7

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1707

7511

2.34

222.01

1.5

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1774

7956

2.30

220.69

1.4

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

535

1194

4.54

218.73

45.7

41.8

6.90

7.36

ug/l

4.96

480

1092

(3017704) Immunofixation for Urine

517

1132

4.62

216.46

2.8

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

844

2613

3.29

216.26

2.0

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

987

3360

3.00

215.25

2.0

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

986

3356

3.00

215.10

2.0

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

986

3357

3.00

214.99

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

986

3359

3.00

214.76

2.0

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3979

23900

1.76

214.69

12.3

7.6

9.48

9.34

mmol/l

0.63

3842

22932

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6691

46349

1.56

205.10

5.6

3.5

0.80

0.82

mmol/l

20.12

6376

43692

(3052851) Hemolysis interference index of Serum or Plasma

1621

7233

2.31

203.72

3.2

2.54

2.24

index

0.44

784

3698

(3006245) CD3-CD19+ cells/cells in Blood

484

1065

4.60

201.39

3.2

2.2

8.76

11.31

3.25

449

1002

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

776

2390

3.30

200.45

2.1

1.7

—

(3016228) CD19 cells/cells in Blood

438

905

4.89

196.70

1.9

2.1

7.35

8.71

1.64

425

884

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11470

89615

1.44

191.53

3.3

2.7

61.36

69.28

u/l

0.57

10773

83163

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3471

20719

1.76

189.76

5.5

3.9

83.52

88.12

ng/l

1.84

3118

18068

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

557

1438

3.92

187.70

2.5

2.9

42.71

38.40

4.91

318

775

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1273

5302

2.46

186.66

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3455

20691

1.75

186.53

5.6

3.8

1.23

mmol/l

0.74

3185

17772

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6319

44312

1.53

179.76

4.1

3.0

2.69

3.06

e6/l

1.92

3379

20895

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8436

62816

1.47

178.79

2.3

1.8

1.33

1.16

mg/l

3.63

6734

48422

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

578

1588

3.69

178.10

3.7

2.3

921.38

1026.73

u/ml

0.47

568

1574

(3023103) Potassium [Moles/volume] in Serum or Plasma

29228

275236

1.93

176.74

25.9

17.5

3.94

3.96

mmol/l

33.24

28794

269630

(3019550) Sodium [Moles/volume] in Serum or Plasma

29180

274685

1.91

175.93

25.4

17.3

139.43

139.71

mmol/l

76.35

28792

269539

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

445

1028

4.37

174.11

2.8

2.0

27.70

29.43

1.56

424

984

(3000060) B lymphocytes [#/volume] in Blood

391

814

4.85

174.03

2.9

2.1

0.19

0.44

e9/l

1.34

186

402

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9135

69462

1.44

171.90

1.4

1.3

1.20

1.68

u/ml

5.43

2472

19112

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

810

2800

2.94

171.63

1.2

68.13

63.31

u/l

0.37

733

2446

(3025941) Bacteria identified in Stool by Culture

2701

15584

1.80

164.58

1.4

1.2

—

(21494434) Karyotype in Bone marrow

659

2074

3.22

164.19

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

232

308

7.57

163.50

1.8

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

463

1159

4.04

162.83

1.1

3.26

3.90

iu/ml

0.87

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1734

8672

2.06

162.57

9.2

3.6

1.54

1.47

mg/l

3.40

1619

7983

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

238

328

7.30

162.29

1.2

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1853

9505

2.01

161.93

2.7

2.3

340.57

575.15

ug/l

2.75

1709

8991

(3033658) Prothrombin time (PT) actual/Normal

9299

71583

1.42

161.20

6.1

4.1

91.61

91.32

0.56

9094

69976

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

580

1708

3.44

160.82

2.3

1.4

25.39

24.75

u/ml

0.11

177

265

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

352

717

4.95

160.78

1.9

2.1

2.20

1.63

ratio

5.76

339

692

(3005322) IgE [Units/volume] in Serum or Plasma

3222

19774

1.70

157.55

1.4

1.3

376.79

220.23

u/ml

3.77

3030

18449

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

637

2025

3.19

156.07

1.5

1.2

76.21

81.36

0.93

116

(3016650) Hepatitis A virus Ab [Presence] in Serum

1116

4797

2.37

152.20

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

736

2599

2.87

149.93

1.9

1.2

61.61

59.63

u/ml

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5794

41271

1.49

149.14

3.2

2.1

29.56

29.54

0.09

5665

40144

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

867

3353

2.63

148.19

1.3

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

319

649

4.95

145.93

2.3

3.5

2.06

1.80

ratio

1.70

298

589

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7166

53383

1.44

145.93

2.9

3.0

2.45

mmol/l

7.61

6524

47854

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

78.12

145.63

1.2

28.40

24.55

mg/l

—

(3044927) Protein electrophoresis panel - Urine

641

2146

3.03

143.70

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

311

641

4.89

140.12

1.4

1.2

40.37

39.82

g/l

0.23

187

312

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

622

2084

3.02

139.24

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

622

2084

3.02

139.24

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

622

2084

3.02

139.24

1.9

1.6

—

(40768797) Stomach Pathology biopsy report

5482

39120

1.49

138.55

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

347

791

4.42

138.14

1.5

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

217

325

6.71

137.11

1.9

2.9

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3404

21912

1.62

137.00

3.2

2.7

67.22

68.30

ml/min/173m2

0.79

1477

9080

(3007916) DNA double strand Ab [Titer] in Serum

190

246

7.76

136.86

1.6

1.2

126.52

181.19

titre

0.23

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3919

26103

1.57

136.50

3.7

3.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7340

55563

1.42

134.95

1.9

1.7

22380792.14

34808949.78

pmol/l

1.12

6394

46661

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

182

232

7.88

132.85

1.5

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

243

422

5.79

132.52

7.1

6.4

1947.89

4505.81

iu/ml

0.79

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

494

1486

3.36

132.45

1.5

1.2

98.91

69.06

titre

0.46

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1073

4824

2.27

131.62

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

500

1528

3.31

130.70

1.6

1.2

387.12

613.42

titre

0.63

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12255

101282

1.34

129.34

4.4

3.5

108.25

53.69

ng/l

0.74

8577

66167

(3042631) Mycobacterium sp identified in Specimen

790

3129

2.56

128.50

2.9

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1020

4545

2.28

127.77

1.3

1.2

4.53

3.33

u/ml

1.01

458

1691

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

793

3172

2.54

126.35

2.2

32.92

32.39

2.76

783

3152

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

461

1372

3.39

125.72

1.3

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15270

130820

1.32

123.68

3.4

2.7

—

estimate

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

145

155

9.39

121.80

4.2

2.1

—

(3037121) Protein [Mass/volume] in Urine

1655

8982

1.89

121.58

4.1

3.4

337.57

507.01

mg/l

2.28

879

4142

(40768446) Kidney Pathology biopsy report

391

1081

3.65

119.39

2.0

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2534

15696

1.67

117.87

1.9

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

353

918

3.87

117.79

1.3

1.2

0.57

0.30

g/l

0.59

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

22.41

116.22

8.2

3.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3962

27334

1.51

116.01

7.3

4.0

5.78

5.82

kpa

1.74

3865

26703

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

491

1597

3.10

115.72

1.3

78.89

94.27

u/l

2.36

430

1366

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

484

1562

3.13

115.60

1.3

22.42

24.58

u/l

0.36

419

1311

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

101

14.88

114.08

5.8

2.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

103

14.34

113.97

6.0

2.6

377997.93

117805.00

u/ml

0.37

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

539

1868

2.92

113.59

1.7

1.4

—

(40768441) Liver Pathology biopsy report

558

1974

2.86

113.25

1.6

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

765

3168

2.45

113.13

2.5

23.74

27.42

iu/ml

0.40

309

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2805

18009

1.61

112.83

6.2

3.7

5.06

5.15

kpa

7.03

2712

17214

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

967

4444

2.21

112.30

1.3

1.2

4.16

3.85

u/ml

0.36

476

2070

(3012544) pH of Venous blood

3977

27688

1.50

111.05

7.4

4.0

7.38

0.35

2316

15791

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

136

153

8.92

109.89

1.1

32.47

32.63

u/ml

0.01

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

136

153

8.92

109.89

1.1

20.61

27.55

u/ml

0.50

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

463

1501

3.11

109.74

1.7

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

122

121

10.11

108.26

4.1

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

468

1543

3.06

107.76

1.6

1.5

6.27

7.02

u/l

0.48

383

1213

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4610

33259

1.45

107.01

4.1

2.7

7.12

8.31

umol/l

3.87

4038

28993

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

567

2086

2.75

106.86

1.1

—

(3009343) pH of Capillary blood

2715

17519

1.60

106.65

6.3

3.7

7.42

3.78

2292

14541

(3000012) Reticulocyte production index

784

3374

2.36

106.38

2.2

0.92

0.90

0.48

591

2228

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

115

108

10.67

106.01

9.9

2.6

—

(3002032) Base excess in Venous blood by calculation

3823

26642

1.49

105.83

7.4

4.0

1.73

1.77

mmol/l

0.25

3400

23510

(3042733) HLA Ab [Presence] in Serum

338

919

3.70

105.82

4.5

5.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

603

2306

2.64

105.33

1.2

1.1

47.53

41.92

mg/l

1.59

502

1967

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

399

1230

3.27

102.88

1.1

217.02

210.72

iu/ml

0.10

393

1222

(40761511) CBC panel - Blood by Automated count

29285

280651

1.66

102.49

23.1

13.0

—

82.29

—

(3010421) pH of Blood

1489

8259

1.84

101.75

4.4

3.5

7.41

0.62

1477

8144

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

582

2227

2.64

101.54

1.1

251.62

266.73

mg/l

0.69

506

1987

(3007461) Platelets [#/volume] in Blood

30597

297358

2.27

100.65

48.7

21.9

263.11

254.22

e9/l

102.27

30418

291458

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

432

1418

3.07

100.26

1.7

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

419

1355

3.12

99.76

1.8

1.4

—

(3023419) Bacteria identified in Sputum by Culture

747

3244

2.33

99.26

2.4

2.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4299

31016

1.45

99.04

9.5

7.9

12.26

12.72

kpa

6.81

4146

29919

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4300

31032

1.45

98.90

9.5

7.9

5.03

5.10

kpa

5.73

4143

29946

(3024731) MCV [Entitic mean volume] in Red Blood Cells

30597

297457

2.25

98.87

48.3

21.8

92.64

90.72

307.65

30523

294648

(3035941) MCH [Entitic mass]

30597

297457

2.25

98.87

48.3

21.8

30.69

30.23

307.65

30524

294652

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

30597

297476

2.25

98.53

49.3

22.3

40.17

41.03

20.01

30524

294557

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

143

195

7.36

98.52

4.4

4.1

2.14

2.15

mg/l

0.02

113

175

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

576

2227

2.61

98.42

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

30597

297487

2.25

98.34

48.5

21.8

4.38

4.52

e12/l

307.65

30353

290662

(3010813) Leukocytes [#/volume] in Blood

30599

297524

2.25

98.16

48.6

21.9

6.80

6.68

e9/l

20.34

30361

290682

(3000963) Hemoglobin [Mass/volume] in Blood

30597

297550

2.24

97.22

48.8

22.0

133.26

135.81

g/l

193.35

30526

294800

(3019977) pH of Arterial blood

4289

31070

1.44

96.43

9.5

8.0

7.42

5.51

2361

16607

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

331

950

3.51

95.59

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

448

1544

2.93

95.40

1.2

1.1

1.08

1.14

u/l

0.65

199

621

(3045142) Bone marrow Pathology biopsy report

675

2868

2.38

94.27

1.3

1.4

—

(4268621) Lupus anticoagulant assay

726

3186

2.31

94.14

2.3

—

(3016502) Oxygen saturation in Arterial blood

3864

27564

1.46

94.11

9.9

8.3

95.54

95.77

1.44

3748

26640

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1544

8877

1.78

93.51

4.8

2.6

3.52

3.56

g/l

0.51

1481

8506

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2522

16476

1.58

93.40

8.4

4.2

24.15

24.24

mmol/l

0.75

2502

16302

(3003396) Base excess in Arterial blood by calculation

4240

30819

1.43

93.30

9.5

7.9

0.91

0.90

mmol/l

0.06

3571

25613

(3048879) Bone marrow aspiration report

238

554

4.32

92.36

2.0

1.9

2.00

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

478

1738

2.77

92.17

1.3

1.2

0.73

0.64

ratio

1.31

282

1003

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

762

3446

2.24

91.97

1.6

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

201

414

4.88

90.76

1.8

1.3

273410.94

11216.57

u/ml

0.47

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

772

3533

2.21

90.50

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

760

3456

2.23

90.50

1.6

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

227

519

4.39

90.16

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2366

15350

1.58

90.15

6.3

3.6

1.62

1.70

mmol/l

0.51

1779

11309

(3010838) Calcium [Moles/time] in 24 hour Urine

1003

5126

1.99

87.71

2.0

1.9

4.90

5.18

mmol/24h

1.92

917

4599

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8421

68726

1.31

87.57

3.1

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

335

1026

3.29

87.36

3.3

1.12

1.40

2.04

335

1026

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1322

7409

1.82

87.13

1.9

1.3

540.76

530.31

mg/l

0.11

1283

7090

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1577

9316

1.73

86.70

4.5

2.3

94.76

93.52

1.39

1534

8964

(3014111) Lactate [Moles/volume] in Serum or Plasma

3484

24763

1.46

85.90

10.9

7.8

1.31

1.33

mmol/l

0.53

3417

24328

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

377

1254

3.03

85.55

2.2

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

193

404

4.80

85.51

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

277

761

3.66

85.49

1.2

—

(3024932) HLA-DR beta [Type]

293

836

3.53

85.43

1.1

—

(3024471) HLA-A [Type]

297

857

3.49

85.11

1.0

—

(3033099) Centromere Ab [Titer] in Serum

252

653

3.88

84.63

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

662

2923

2.29

84.61

1.1

53.50

64.55

au/ml

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

165

304

5.45

84.59

10.5

9.3

0.48

0.38

umol/l

0.69

119

290

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

375

1253

3.01

84.43

2.2

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

375

1253

3.01

84.43

2.2

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

375

1253

3.01

84.43

2.2

1.8

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

675

3012

2.27

84.13

1.1

28.92

21.29

au/ml

—

(37208534) Antinuclear antibody arbitrary concentration in serum

307

927

3.33

81.94

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1191

6591

1.84

81.74

1.9

1.3

3.63

3.74

mmol/l

3.14

1131

6248

(3024354) Oxygen [Partial pressure] in Venous blood

3233

22895

1.46

80.93

6.7

3.4

4.67

4.61

kpa

0.87

3143

22324

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

711

3312

2.17

79.74

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

711

3316

2.17

79.49

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

708

3302

2.17

79.16

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

571

2456

2.35

77.57

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

361

1239

2.93

77.53

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

361

1239

2.93

77.53

1.5

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

758

3660

2.10

77.47

7.6

6.2

11.82

11.59

mg/l

0.64

713

3396

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

816

4057

2.04

77.06

1.1

1.52

1.49

g/l

1.48

774

3711

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

292

890

3.30

76.80

2.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

292

890

3.30

76.80

2.3

2.0

—

(3019225) pH of Specimen

3461

25066

1.43

76.46

6.2

4.0

7.36

1.16

2922

17704

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1161

6507

1.81

76.39

2.1

1.4

28.48

33.53

e6/l

0.18

869

4801

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1173

6595

1.81

76.38

2.1

1.4

1230.63

2415.48

e6/l

0.71

931

5171

(3006922) Hepatitis E virus Ab [Presence] in Serum

543

2302

2.38

76.24

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

294

904

3.27

76.23

2.3

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

301

940

3.22

76.09

2.9

2.8

0.60

0.61

mmol/l

1.71

301

940

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2732

18948

1.48

75.82

13.7

8.2

24.80

24.81

mmol/l

0.06

2717

18820

(3014765) Yersinia sp identified in Stool by Organism specific culture

1299

7568

1.75

74.86

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1300

7585

1.74

74.53

1.2

—

(3013727) Leukocytes other/Leukocytes in Blood

249

699

3.58

74.47

3.9

3.3

51.99

52.55

0.15

240

679

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1524

9288

1.67

74.41

4.5

2.8

24.44

24.73

mmol/l

2.40

1504

9118

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1135

6395

1.80

73.35

2.7

2.2

126.98

130.83

g/l

5.35

770

4993

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3541

25962

1.41

72.72

10.6

8.7

118.32

121.69

g/l

19.30

3476

25379

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1435

8664

1.69

72.58

4.2

2.5

201.47

186.91

7.75

1373

8236

(3036489) Thrombin time

1736

11029

1.61

71.76

3.7

2.1

21.35

20.94

1.43

1563

9718

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1283

7539

1.73

71.68

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1619

10128

1.63

71.28

2.4

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

346

1221

2.85

70.67

1.2

1.1

25.39

9.31

u/ml

0.75

130

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

224

609

3.69

70.29

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

162

346

4.70

70.14

2.1

2.0

—

(3001729) Color of Synovial fluid

100

135

7.42

69.58

2.5

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

100

135

7.42

69.58

1.1

—

(3036603) Volume of Urine

484

2035

2.40

69.25

2.4

1.5

1966.51

1984.87

0.17

478

1991

(3042951) Complement C1q Ab [Units/volume] in Serum

8.96

69.07

1.5

1.1

21.54

18.89

u/ml

0.16

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

419

1655

2.55

68.60

1.2

1.1

1.08

1.06

ratio

1.28

366

1360

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

147

295

5.00

68.53

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1226

7203

1.73

68.50

7.5

3.6

8.62

8.48

kpa

1.70

1205

7024

(3020891) Body temperature

1873

12253

1.56

68.19

5.0

4.7

36.92

36.91

°c

0.80

1854

12146

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

988

5474

1.83

67.45

4.3

3.4

8.05

9.02

pmol/l

2.21

988

5468

(1616796) Gas panel - Central venous blood

1049

5921

1.80

67.35

4.9

3.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2143

14490

1.51

67.00

1.1

140.00

191.80

titre

0.45

401

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3659

27387

1.38

65.97

2.9

2.6

41.45

49.01

u/l

0.68

3189

23200

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1483

9278

1.63

65.17

2.1

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

282

937

3.03

64.23

4.8

1.4

40.10

40.37

g/l

0.31

282

937

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2731

19597

1.43

62.77

3.7

2.9

174.28

179.09

ng/l

0.24

2494

17890

(3014007) Fractional oxyhemoglobin in Arterial blood

2525

17869

1.45

62.57

12.3

10.1

93.83

94.05

0.97

2519

17810

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

520

2371

2.21

61.56

3.7

3.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1333

8250

1.64

61.11

5.1

3.2

0.34

0.36

iu/ml

1.09

705

4514

(3039744) RNA polymerase III Ab [Units/volume] in Serum

108

183

5.91

60.60

1.0

1.1

4.21

5.28

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

236

733

3.23

60.30

1.7

1.5

—

(4035726) Immunohistochemistry procedure

3233

24058

1.38

60.01

1.5

1.4

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

112

7.51

59.11

2.8

1.2

0.44

0.84

(3021901) Oxygen saturation in Capillary blood

950

5420

1.77

58.78

4.4

3.0

90.54

90.49

0.09

934

5268

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2494

17807

1.43

58.75

12.3

9.9

1.27

1.33

3.13

2474

17707

(3020717) Zinc [Moles/volume] in Serum or Plasma

395

1647

2.41

57.65

1.6

1.5

17.08

24.35

umol/l

7.42

378

1525

(3032352) Blasts [#/volume] in Cerebral spinal fluid

130

273

4.77

57.52

4.7

1.7

—

(40758292) HTLV I+II Ab panel - Serum

176

466

3.79

57.48

1.6

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

781

4246

1.86

56.64

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

450

2021

2.24

55.32

1.2

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

901

5156

1.77

55.17

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

901

5156

1.77

55.17

1.4

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

370

1532

2.43

54.87

1.2

1.1

76.32

82.53

u/l

0.79

348

1356

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

368

1521

2.43

54.78

1.2

1.1

22.30

22.37

u/l

0.01

347

1345

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2278

16200

1.44

54.69

12.6

9.9

24.34

24.28

mmol/l

0.33

2226

15895

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2144

15089

1.45

54.43

1.1

11.62

10.64

u/ml

0.04

160

(3027315) Oxygen [Partial pressure] in Blood

936

5447

1.74

54.04

5.0

3.8

8.68

8.71

kpa

0.17

923

5323

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2399

17267

1.42

53.85

12.7

10.2

0.66

0.64

2.04

2383

17178

(40767503) Oxygen content in Capillary blood by calculation

939

5475

1.74

53.84

3.3

2.6

16.21

16.63

4.23

922

5352

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

351

1432

2.47

53.76

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2552

34385

0.72

53.30

1.8

1.9

3.47

3.49

ratio

0.33

1982

26126

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

377

1602

2.37

52.78

1.6

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

373

1579

2.38

52.67

1.6

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

924

5417

1.73

51.95

5.1

3.8

4.92

5.02

kpa

4.55

911

5294

(3012501) Base excess in Blood by calculation

923

5416

1.72

51.73

5.1

3.8

2.34

2.49

mmol/l

1.10

670

3639

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1807

25696

0.68

51.38

1.5

1.7

3.41

3.50

mmol/l

2.68

1220

17379

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2252

16159

1.42

51.34

7.1

7.0

24.53

24.54

mmol/l

0.06

2166

15485

(3022621) pH of Urine by Test strip

2969

22322

1.36

51.20

3.3

2.4

6.04

6.08

2.00

1940

14577

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1994

14006

1.45

51.05

5.4

3.1

0.65

0.62

3.37

1986

13964

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

434

1989

2.20

50.81

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

23237

219395

1.23

50.81

4.7

4.5

14.90

14.68

pmol/l

34.19

21714

203272

(3020393) Adenovirus Ag [Presence] in Stool

130

304

4.29

50.36

2.2

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

183

545

3.37

50.13

1.2

47.30

17.75

u/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

428

1966

2.19

49.83

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

796

4528

1.78

49.75

1.2

1.1

0.97

1.05

0.11

195

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1489

9917

1.53

49.65

7.2

4.0

24.64

24.80

mmol/l

1.55

1401

9209

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

144

368

3.92

49.51

1.8

1.5

—

(36660697) Celiac disease serology panel - Serum

3205

24509

1.34

49.34

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1996

14135

1.44

48.85

5.4

3.1

1.20

1.28

3.51

1983

14075

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

282

1089

2.60

48.52

4.3

4.0

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

155

426

3.65

48.03

1.4

1.0

40.03

2.38

iu/ml

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

161

456

3.54

47.70

3.0

2.7

48.40

42.01

mg/l

0.17

121

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

289

1139

2.55

47.69

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

289

1139

2.55

47.69

1.6

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6232

52132

1.24

47.25

4.5

3.8

324.70

456.07

ng/l

1.71

4733

38706

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

26659

256051

1.27

47.04

5.6

5.5

1.85

1.87

mu/l

1.53

25182

239407

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

237

851

2.80

47.04

1.1

2.46

6.38

u/ml

1.47

(3012565) Volume of 24 hour Urine

312

1284

2.44

46.96

3.1

2.0

2002.34

1975.57

0.17

290

1150

(3044889) 12 lead EKG panel

20400

190740

1.20

46.82

4.4

3.9

0.43

3167.63

1.34

376

(3013247) Albumin in CSF/Albumin in Serum or Plasma

193

625

3.10

46.11

1.1

7.18

6.89

mg/g

0.21

184

595

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

135

349

3.88

45.71

1.3

1.6

56082.16

274145.09

nmol/l

1.29

107

290

(3023410) Appearance of Cerebral spinal fluid

571

3018

1.91

45.25

2.9

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

171

521

3.29

45.22

2.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

181

571

3.18

45.21

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

473

2350

2.03

44.86

1.3

1.2

106.41

112.44

pmol/l

1.78

473

2350

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

118

281

4.21

44.69

1.7

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

373

1710

2.19

43.71

1.4

13.65

12.58

u/l

1.46

361

1661

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

205

4.79

43.66

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2744

20934

1.34

42.58

2.4

2.3

8.51

7.30

ug/l

1.09

2422

18451

(3013005) Retinol [Moles/volume] in Serum or Plasma

319

1393

2.30

42.06

2.4

1.9

2.06

1.92

umol/l

1.73

306

1276

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

720

4212

1.72

40.83

1.1

3.43

2.78

0.94

751

(3013512) EKG study

10305

91530

1.19

40.79

3.7

3.5

0.77

0.74

0.13

223

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

107

254

4.22

40.73

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2225

16554

1.37

40.59

5.9

3.4

125.22

130.03

g/l

19.67

2161

16108

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1796

12960

1.41

39.36

4.9

4.0

49.22

48.24

0.94

1760

12799

(3028271) Lactate [Moles/volume] in Capillary blood

689

4038

1.72

38.83

2.2

1.8

1.67

1.72

mmol/l

0.83

673

3930

(3018405) Lactate [Moles/volume] in Arterial blood

1224

8275

1.50

37.90

3.9

4.3

1.34

1.38

mmol/l

0.83

1199

8115

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

534

2928

1.84

37.79

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

488

2610

1.88

37.37

4.3

3.4

16.28

14.19

index

1.50

325

1468

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

443

2311

1.93

36.61

1.1

288.21

289.51

mg/l

0.13

416

2108

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2092

15686

1.36

36.19

13.1

9.9

15.57

16.13

17.21

2029

15159

(3012516) Albumin [Mass/volume] in Urine

9880

88178

1.17

35.56

4.1

3.5

51.10

46.71

mg/l

1.18

6658

55367

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1255

8669

1.47

34.87

1.5

1.4

285.37

276.65

ug/g

0.77

721

4999

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

365

1811

2.03

34.87

3.8

2.1

100.56

97.99

0.64

353

1696

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1164

7934

1.48

34.61

1.2

4.44

3.82

1.07

110

1183

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

508

2826

1.81

34.34

1.4

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

301

1400

2.16

34.14

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

126

382

3.30

33.72

6.2

5.3

42.35

40.72

ug/min

0.11

102

291

(3009508) Creatinine [Moles/volume] in Urine

10720

96592

1.17

33.68

4.1

3.5

7.41

7.64

mmol/l

5.71

9342

82414

(3022806) Fractional oxyhemoglobin in Capillary blood

538

3063

1.77

33.64

1.9

1.8

90.13

89.96

0.34

526

3014

(3003181) Sodium [Moles/volume] in Urine

772

4856

1.60

33.11

1.6

1.5

62.54

62.30

mmol/l

0.05

618

3852

(3029634) Reagin Ab [Titer] in Serum by VDRL

684

4184

1.65

32.85

1.9

2.2

6.33

9.74

titre

0.31

112

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.36

32.72

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

325

1584

2.06

32.64

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1891

14208

1.35

32.19

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

234

1016

2.31

31.41

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1122

7753

1.46

31.12

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

113

337

3.36

31.09

1.4

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

427

2324

1.85

31.04

3.1

2.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

9950

89558

1.16

30.97

4.8

4.2

11.16

8.23

mg/mmol

1.01

6557

55075

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1385

9961

1.41

30.85

1.3

219.84

221.35

miu/ml

0.05

518

4646

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

691

4310

1.62

30.71

1.1

120.21

117.92

1.00

650

3911

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

211

897

2.36

29.76

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1571

11615

1.37

29.63

4.8

3.5

25.20

25.27

mmol/l

0.36

1517

11229

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

20478

194338

1.15

29.49

4.3

3.3

50.15

45.92

u/l

8.31

19541

183845

(3011325) HIV 1+2 Ab [Presence] in Serum

105

5.43

29.44

1.1

0.08

0.85

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

168

650

2.59

29.03

1.6

1.9

20.68

40.62

u/l

2.30

145

590

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

412

2268

1.83

28.91

1.3

2.16

2.09

mmol/l

0.29

387

2107

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

206

881

2.34

28.69

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

703

4481

1.58

28.55

1.1

—

(4195642) Thrombophilia screening test

674

4262

1.59

28.33

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

318

1621

1.97

28.25

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

200

851

2.36

28.19

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

2354

29517

0.78

28.14

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

144

526

2.74

27.90

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

273

3.48

27.74

1.1

216.81

298.45

u/ml

1.09

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

544

3288

1.66

27.45

1.1

97.48

96.53

0.35

514

3095

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

526

3152

1.68

27.43

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

174

707

2.47

27.17

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

244

1149

2.13

26.94

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

1004

6986

1.45

26.87

4.1

4.6

3.86

3.87

mmol/l

0.07

993

6931

(3022493) Free Hemoglobin [Mass/volume] in Plasma

254

1218

2.09

26.75

3.8

4.7

1236.88

2043.63

mg/l

0.38

210

886

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

170

692

2.46

26.46

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

640

2.52

26.36

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

256

1243

2.07

26.09

5.4

2.1

49.75

236.50

ug/l

1.29

249

1180

(3009015) Lactate [Moles/volume] in Synovial fluid

248

3.51

25.75

1.4

1.2

5.41

6.32

mmol/l

0.86

118

(40765096) Chromosome analysis panel by Banding

177

744

2.38

25.69

1.2

1.1

—

(3003129) Base excess in Capillary blood by calculation

520

3172

1.65

25.35

2.8

2.1

0.47

0.56

mmol/l

0.18

499

3037

(3034426) Prothrombin time (PT)

199

888

2.25

25.16

1.2

27.91

28.17

0.27

199

888

(3045716) Anion gap in Serum or Plasma by calculation

472

2819

1.68

24.97

3.2

3.1

10.36

10.83

mmol/l

1.86

466

2778

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

372

2092

1.79

24.41

1.4

13.00

12.21

umol/l

1.37

363

1971

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

132

495

2.67

24.37

1.4

1.2

—

(3000330) Specific gravity of Urine by Test strip

1701

13116

1.31

24.11

3.8

3.2

1.02

ratio

1.29

1553

11716

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2708

22148

1.24

23.76

1.6

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

317

1712

1.86

23.76

1.3

18.87

14.23

u/l

1.10

297

1581

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1550

11833

1.32

23.59

5.6

4.9

1.59

1.65

1.69

1478

11224

(3017569) Oxygen content in Arterial blood

259

1322

1.97

23.04

2.3

2.2

15.89

15.98

0.17

259

1322

(3010937) Rubella virus Ab [Presence] in Serum

166

3.92

22.60

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

310

1697

1.83

22.29

1.2

1.1

10.63

4.54

nmol/l

1.62

100

278

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

550

3516

1.57

22.16

1.5

1.9

12977.78

3005.17

titre

—

147

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

241

1220

1.98

21.98

1.1

1.2

—

(4024509) Urine culture

1607

12466

1.30

21.78

2.1

1.9

—

(3018133) Calcium [Moles/volume] in Urine

148

622

2.38

21.59

1.7

2.2

2.61

2.73

mmol/l

0.28

133

569

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

679

4575

1.49

21.48

1.3

45.28

30.28

u/l

2.81

618

3971

(3036048) Francisella tularensis Ab [Titer] in Serum

148

625

2.37

21.36

1.2

1.1

704.00

580.61

titre

—

(3024928) Oxygen saturation in Venous blood

970

6999

1.40

21.24

7.1

3.4

63.48

62.66

0.56

947

6778

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

26273

255658

1.17

21.04

6.4

6.1

38.20

38.94

mmol/mol

40.00

25074

240837

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

160

708

2.26

20.75

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3599

30675

1.19

20.69

8.1

6.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

104

376

2.77

20.69

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

211

1045

2.02

20.50

1.1

1.2

913.64

1030.18

titre

0.64

222

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

348

2024

1.73

20.41

1.3

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

108

402

2.69

20.32

2.0

1.2

801.25

112.56

ng/l

0.46

255

(3016038) Potassium [Moles/volume] in Urine

317

1806

1.76

20.00

1.4

1.3

31.84

34.22

mmol/l

1.13

274

1586

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

134

4.03

19.58

3.3

5.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

109

4.40

19.53

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

160

728

2.20

19.43

1.7

1.6

0.32

0.41

ug/l

2.46

128

527

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3786

32595

1.18

19.31

2.0

2.1

—

(3047181) Lactate [Moles/volume] in Blood

1067

7944

1.35

19.27

6.1

5.7

1.31

1.30

mmol/l

0.03

938

7049

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

407

2506

1.63

19.26

1.8

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

502

3252

1.55

19.15

1.5

1.4

34.23

42.83

g/l

0.45

470

2966

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

367

2208

1.67

19.02

1.4

1.3

533.41

477.88

u/l

0.43

346

2099

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4094

35537

1.17

18.87

2.1

2.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

285

2.95

18.81

1.3

1.2

1.20

1.83

iu/ml

3.28

150

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

254

1381

1.84

18.76

1.3

61.47

65.02

0.22

159

(3023183) Ammonium ion [Moles/volume] in Plasma

837

6024

1.40

18.65

2.9

2.8

33.01

34.05

umol/l

0.59

775

5451

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

227

1201

1.89

18.27

1.2

1.1

311.61

514.97

ng/l

0.53

322

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

262

1452

1.81

18.20

1.5

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

228

3.16

18.17

1.2

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

382

2354

1.63

18.05

1.4

1.3

5.78

6.34

mmol/l

3.44

352

2197

(3019832) Treponema pallidum Ab [Presence] in Serum

3489

30017

1.18

17.86

1.7

1.8

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

244

3.03

17.46

1.6

1.7

0.98

1.84

mg/l

1.12

174

(3007930) Methemoglobin/Hemoglobin.total in Blood

1376

10771

1.29

17.42

5.9

5.2

0.86

0.89

1.49

1309

10193

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

321

2.74

17.29

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

143

3.71

17.15

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

268

1526

1.76

17.03

1.4

1.6

1709517.80

2247375.02

iu/ml

—

101

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

319

2.73

16.94

1.1

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

238

3.03

16.93

1.6

0.43

1.01

mg/l

2.05

174

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

238

3.03

16.93

1.6

4.52

3.89

mg/l

0.22

165

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

238

3.03

16.93

1.6

1.77

2.44

mg/l

0.59

181

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

238

3.03

16.93

1.6

1.71

2.19

mg/l

0.27

169

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

238

3.03

16.93

1.6

2.63

2.70

mg/l

0.03

174

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

238

3.03

16.93

1.6

1.70

1.08

mg/l

0.36

158

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

238

3.03

16.93

1.6

0.98

2.24

mg/l

2.63

189

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

239

3.01

16.81

1.6

1.41

1.67

mg/l

0.33

182

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

239

3.01

16.81

1.6

1.79

1.68

mg/l

0.07

160

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

235

3.02

16.66

1.2

0.25

0.58

iu/ml

3.68

125

(3016244) Insulin [Units/volume] in Serum or Plasma

327

1984

1.65

16.48

3.3

3.2

23.39

26.12

mu/l

0.64

316

1868

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.40

16.28

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

447

2931

1.53

16.23

1.5

2950.79

3521.90

e6/l

0.37

306

2045

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

892

11791

0.75

15.71

1.1

1.53

1.52

g/l

0.21

892

11779

(3001686) Cold agglutinin [Titer] in Serum or Plasma

110

469

2.35

15.68

1.2

1.4

8.60

380.96

titre

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

835

11128

0.74

15.56

1.1

0.56

0.63

ratio

2.99

109

1322

(40761539) Cells [Type] in Urine sediment by Light microscopy

131

604

2.17

15.51

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

400

2.45

15.40

7.7

4.6

513.42

60.47

mg/mmol

0.48

360

(44806071) Cardiolipin IgM antibody measurement

383

2.48

15.33

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

232

2.93

15.17

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

163

824

1.98

15.11

1.2

1.3

16.58

16.67

umol/l

0.06

150

710

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

110

3.91

15.03

2.0

1.3

—

(3022229) Phosphate [Moles/volume] in Urine

208

3.03

14.89

1.8

2.5

19.56

18.90

mmol/l

0.07

178

(3007919) Fasciola sp Ab [Titer] in Serum

5.74

14.87

1.1

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

139

667

2.09

14.87

1.2

6.92

12.07

pmol/l

3.57

250

(3019174) dRVVT (LA screen)

227

2.91

14.53

1.2

—

(4034850) Laboratory test

1063

8259

1.30

14.30

13.2

9.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1072

13643

0.78

14.22

1.5

1.6

995.79

1015.74

mu/l

0.27

863

11460

(3004451) EKG impression Narrative

240

1397

1.72

14.21

1.4

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

138

3.48

14.20

3.5

3.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

388

2.40

13.98

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

283

1729

1.64

13.97

1.5

1.6

7.31

8.88

ug/l

0.58

256

1589

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

714

5258

1.37

13.95

1.1

18.81

15.46

au/ml

0.54

147

1374

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

119

555

2.15

13.75

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

119

556

2.14

13.69

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

119

556

2.14

13.69

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

364

2376

1.54

13.59

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

27537

270316

1.15

13.54

5.2

5.0

4.60

4.68

mmol/l

43.22

26131

255188

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

105

3.81

13.52

3.9

4.0

—

(40768806) Pleura Pathology biopsy report

372

2443

1.53

13.50

1.6

1.5

—

(3002619) Bacteria identified in Specimen by Culture

143

720

1.99

13.47

1.4

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

168

3.16

13.46

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

661

2.03

13.37

1.2

1.1

—

(3016750) Collection duration of Urine

234

1378

1.70

13.32

2.7

2.2

503.94

497.40

min

0.43

184

1044

(3032057) Clostridioides difficile [Presence] in Stool

105

472

2.23

13.31

2.0

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

345

2241

1.54

13.18

2.0

1.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

523

7292

0.71

13.07

1.4

1.5

1.13

1.19

ratio

0.81

295

4398

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

523

7291

0.71

13.06

1.4

1.5

0.95

ratio

0.02

291

4363

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

521

7264

0.71

13.02

1.4

1.5

1.19

1.16

ratio

0.20

289

4337

(3002256) Pathology report gross observation

4241

37847

1.14

12.99

1.3

—

(40757373) Influenza virus identified in Isolate

101

452

2.24

12.95

2.0

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

441

3026

1.46

12.94

4.0

7.9

7.27

7.37

mmol/l

0.17

375

2511

(3019768) Coxiella burnetii Ab [Presence] in Serum

157

3.19

12.91

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

167

900

1.86

12.87

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

681

9083

0.74

12.82

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

515

7173

0.71

12.80

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

229

1357

1.69

12.76

1.8

1.7

1.47

2.61

u/field

2.99

156

975

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

323

4902

0.65

12.74

2.6

3.9

24.03

39.41

u/ml

4.09

312

4738

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.85

12.73

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.75

12.69

1.1

—

(3035880) pH of Pleural fluid

208

1203

1.73

12.67

1.3

7.39

7.41

0.93

145

839

(3039000) Anion gap in Blood by calculation

720

5396

1.34

12.59

7.4

6.8

11.22

11.24

mmol/l

0.08

656

4874

(3018572) Chloride [Moles/volume] in Blood

720

5397

1.34

12.57

7.4

6.8

105.02

105.14

mmol/l

0.26

656

4876

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

131

657

2.00

12.52

1.8

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

135

3.33

12.51

8.0

11.0

394.91

138.18

e6/l

0.55

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2873

32812

0.86

12.40

1.6

1.7

—

6.72

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1534

12655

1.22

12.32

1.6

1.8

0.29

0.31

mg/l

0.89

702

6051

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

228

1366

1.67

12.22

1.3

1.2

13.37

9.61

mm/h

2.99

228

1366

(3028308) Erythrocytes [#/volume] in Pleural fluid

386

2615

1.48

12.12

1.5

1.4

47895.33

52215.73

e6/l

0.13

206

1463

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

740

5613

1.32

11.94

3.4

3.6

337.87

945.15

u/ml

2.58

659

5093

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1007

7970

1.27

11.77

1.1

4.13

6.28

eliau/ml

1.04

1085

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

27799

273444

1.14

11.66

5.7

2.65

2.76

mmol/l

85.11

26292

257177

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

240

2.63

11.53

1.1

20.75

21.85

u/l

0.19

157

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

705

1.92

11.52

1.1

—

(3024316) Viscosity of Plasma

118

3.39

11.44

1.3

1.7

1.64

1.53

mpas

0.38

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.00

11.43

4.7

3.4

—

(4015189) Microbial culture of sputum

118

594

1.99

11.21

1.8

2.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

450

3188

1.42

11.19

2.4

1.9

26.14

24.81

mg/l

0.22

186

1157

(3027035) Albumin [Mass/time] in 24 hour Urine

222

2.66

11.08

1.8

1.3

213.50

296.78

mg/24h

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

429

5989

0.71

10.88

1.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

291

4358

0.66

10.83

4.9

5.7

350.92

369.03

umol/l

1.50

248

3840

(3005033) Fetal Nuchal fold Thickness US

421

5888

0.71

10.80

1.4

1.5

1.24

1.26

0.52

285

4270

(3026051) Granulocytes/Leukocytes in Pleural fluid

101

490

2.06

10.65

1.3

1.4

32.21

22.11

2.31

417

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

4.22

10.51

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

363

2.23

10.45

1.2

1.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

4.46

10.44

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

126

666

1.89

10.42

1.3

3.87

3.43

mmol/l

0.66

116

619

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1404

11688

1.21

10.33

2.2

2.4

5632.22

5638.67

u/l

0.00

452

4579

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

346

2372

1.46

10.32

1.3

1.43

1.99

u/ml

0.70

195

1387

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

266

2.44

10.31

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

27337

268911

1.12

10.30

5.1

4.9

1.50

1.47

mmol/l

24.78

25812

252577

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

303

2.34

10.27

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

444

2.10

10.25

1.6

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

328

2232

1.47

10.17

3.3

2.6

30.14

27.69

mg/l

0.57

258

1580

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

156

888

1.76

10.16

1.3

26.57

19.94

0.48

143

(3034274) Bile acid [Moles/volume] in Serum --fasting

526

3891

1.36

10.12

3.3

2.1

10.51

7.11

umol/l

2.17

396

2850

(3043238) Trisomy 21 risk [Likelihood] in Fetus

447

6114

0.73

10.03

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

581

7641

0.76

10.00

1.5

66.49

61.82

ug/l

0.71

453

6334

(3035082) Kappa light chains [Mass/volume] in Urine

4.03

9.92

1.1

0.45

0.04

g/l

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.24

9.80

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

209

1306

1.60

9.60

2.5

2.3

28.51

34.89

umol/l

0.18

127

(3003740) Influenza virus B Ag [Presence] in Specimen

737

5763

1.28

9.58

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

737

5764

1.28

9.57

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

190

1162

1.64

9.53

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

223

2.51

9.45

1.1

82.29

93.56

titre

0.73

223

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

994

12164

0.81

9.43

1.2

0.87

0.89

g/l

1.55

994

12128

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

248

2.42

9.36

1.2

0.25

0.39

u/ml

0.29

(3010015) Selenium [Moles/volume] in Serum or Plasma

331

2.21

9.21

1.9

2.0

1.25

1.31

umol/l

0.84

239

(3044242) Glucose [Moles/volume] in Arterial blood

213

1353

1.58

9.16

2.1

2.0

7.90

8.09

mmol/l

0.31

213

1353

(3044416) Complement C4 [Mass/volume] in Pleural fluid

105

3.24

9.12

1.1

1.2

0.07

0.08

g/l

0.38

(3026470) Cobalt [Mass/volume] in Blood

217

1387

1.57

9.09

2.2

3.61

3.58

ug/l

0.02

197

1288

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

164

2.74

9.06

1.1

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

199

2.56

8.99

1.5

2.1

177.53

179.52

ug/g

0.02

175

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.82

8.92

6.7

8.6

—

(3004775) Volume in Urine collected for unspecified duration

274

1860

1.48

8.68

2.5

2.3

757.41

666.46

2.56

201

1297

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

891

10925

0.81

8.64

3.6

1.6

7.42

4.07

mg/l

5.56

746

8069

(3020618) Glucose [Moles/volume] in Synovial fluid

3.54

8.63

1.1

4.64

5.02

mmol/l

0.26

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

6.56

8.62

5.0

5.9

165.87

4015.96

e6/l

0.54

(3027456) Digoxin [Moles/volume] in Serum or Plasma

581

4472

1.30

8.57

3.3

0.81

0.80

nmol/l

0.17

454

3607

(4212803) Bone marrow aspirate examination

193

2.54

8.50

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

259

3774

0.68

8.49

1.2

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

176

2.61

8.46

1.1

1.0

—

(40768795) Lymph node Pathology biopsy report

388

2820

1.38

8.43

1.2

—

(3025577) Chromium [Mass/volume] in Blood

209

1349

1.55

8.42

2.2

2.24

2.40

ug/l

0.28

172

1119

(3008295) Osmolality of Serum or Plasma

409

3001

1.37

8.39

1.4

1.5

277.21

279.66

mosm/kgh2o

1.35

323

2291

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

290

2012

1.44

8.23

2.0

1.9

1.80

3.01

u/field

0.52

159

1133

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3734

33934

1.11

8.22

1.5

—

7.64

—

(46236302) HLA-C [Type] by High resolution typing

107

3.08

8.20

1.0

—

(3003694) ABO and Rh group [Type] in Blood

8756

82744

1.08

8.12

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

376

2.05

8.10

1.3

0.91

1.41

mmol/l

0.57

247

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

222

2.39

8.09

1.4

1.3

1.35

1.55

ml/s/173m2

0.21

152

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.37

8.03

1.0

1.1

1.13

1.35

u/field

0.24

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

141

2.77

8.01

1.0

1.2

0.92

1.24

u/field

2.01

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

831

1.67

7.71

1.5

1.7

—

161.67

iu/ml

—

(40763590) HLA-DQ beta [Type]

106

3.02

7.69

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

551

4277

1.29

7.68

1.1

3.92

3.03

eliau/ml

0.43

190

2101

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

117

2.91

7.65

1.1

1.2

—

(40760409) HLA-A [Type] by High resolution

107

2.99

7.57

1.0

—

(40760410) HLA-B [Type] by High resolution

107

2.99

7.57

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

224

1504

1.49

7.56

1.7

2.0

179.39

143.22

6.53

210

1423

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

301

2.13

7.46

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

2.58

7.38

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

142

2.68

7.36

1.3

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

384

1.98

7.32

3.4

3.0

15.15

14.80

ml/dl

0.38

358

(3006969) Lambda light chains [Mass/volume] in Urine

3.59

7.27

1.1

0.33

0.03

g/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

26032

256218

1.09

7.25

4.5

4.2

1.29

mmol/l

0.02

24444

238658

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

105

2.95

7.19

1.3

1.0

0.04

0.48

mg/l

0.50

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.67

7.16

1.2

1.1

264.45

249.18

u/ml

0.14

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.47

7.15

1.2

1.5

0.70

0.61

u/field

—

(3017400) Magnesium [Moles/volume] in Urine

3.54

7.11

1.1

3.35

3.10

mmol/l

0.17

(4198724) Urine methamphetamine measurement

1491

0.55

7.00

2.3

2.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

323

2.04

6.96

1.2

1.3

517.43

177.62

u/l

0.30

235

(3020650) Glucose [Presence] in Urine

155

982

1.58

6.87

1.9

1.6

0.03

0.05

estimate

0.37

155

982

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

855

7071

1.21

6.86

1.2

1.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

202

2.33

6.83

1.1

1.2

10.81

10.36

mg/l

0.11

185

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1160

9868

1.18

6.83

3.6

561.51

2067.02

u/ml

1.44

998

8502

(3041918) Cholesterol [Moles/volume] in Pleural fluid

459

1.85

6.75

1.2

1.76

1.68

mmol/l

0.17

285

(3013862) HLA-DP [Type]

109

2.84

6.75

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

26425

260453

1.09

6.59

5.0

5.80

5.89

mmol/l

26.89

24723

242134

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

341

2532

1.35

6.59

2.4

2.5

20.94

19.10

nmol/l

2.10

323

2406

(3006270) Folate [Moles/volume] in Blood

274

1965

1.40

6.57

1.2

1.1

352.64

372.34

nmol/l

0.88

242

1690

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

524

6599

0.79

6.57

1.5

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

175

2.40

6.55

1.4

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

324

2.01

6.55

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

304

2220

1.37

6.54

1.1

20.61

18.68

u/ml

0.36

912

(3001019) Free T4 and TSH panel - Serum or Plasma

1352

15570

0.86

6.54

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12382

119124

1.06

6.43

2.0

1.9

1.38

1.36

mmol/l

0.91

10638

100891

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

268

1926

1.39

6.37

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

166

2.41

6.31

1.4

1.5

286.07

323.25

umol/24h

0.53

166

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

413

1.86

6.28

1.3

35.95

42.28

mg/l

0.72

348

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

+∞

6.25

4.0

0.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

152

985

1.54

6.16

1.1

96.85

90.12

1.31

460

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

153

1005

1.52

5.85

1.1

94.37

90.11

0.93

460

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1142

9837

1.17

5.82

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

133

848

1.57

5.82

1.1

2.61

6.66

u/ml

0.51

510

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

192

2.24

5.78

1.0

1.1

50.47

9.98

iu/ml

1.67

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

156

1032

1.51

5.78

1.1

1.2

115.37

107.84

1.31

146

938

(3033086) Enterovirus Ab [Titer] in Serum

3.00

5.77

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

241

3304

0.73

5.71

1.1

—

(3011985) Renin [Units/volume] in Plasma

542

4370

1.24

5.64

1.6

71.81

64.96

mu/l

0.30

488

3929

(44813793) Dust mix specific IgE antibody measurement

296

2211

1.34

5.58

1.0

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

12.85

5.57

4.1

3.1

140.44

138.14

mmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

275

2.00

5.56

4.2

2.8

1.88

1.22

mg/l

0.59

195

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.28

5.56

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

101

1626

0.62

5.51

1.5

1.4

31.73

34.02

nmol/l

0.31

1478

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

177

1215

1.46

5.49

1.1

94.68

97.98

0.70

144

960

(3028707) Methadone [Presence] in Urine by Screen method

462

5772

0.80

5.49

2.4

2.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

212

1506

1.41

5.46

1.3

239.02

336.83

u/l

1.43

196

1401

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

130

840

1.55

5.40

1.3

122.77

129.89

nmol/l

0.22

605

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.81

5.38

1.0

—

(3041184) Isoniazid [Presence] in Urine

5.60

5.35

2.6

2.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

105

647

1.62

5.33

1.3

320.76

276.93

ug/l

0.06

351

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2171

19619

1.11

5.32

3.2

3.5

4.46

4.51

pmol/l

1.08

1982

17716

(3050794) Legionella sp Ab [Presence] in Serum

234

2.05

5.22

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

241

2.03

5.20

1.3

1.4

57.96

72.91

2.16

207

(3046682) IgA [Presence] in Skin by Immunofluorescence

3.75

5.07

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

150

2181

0.69

5.07

1.0

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

3.08

5.04

5.3

5.6

8.83

5.01

mg/l

0.47

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

496

4016

1.24

5.02

1.4

333.49

386.68

pmol/l

0.71

429

3462

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

160

1098

1.46

5.01

1.8

2.1

202.37

162.73

3.58

152

1047

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

162

1116

1.45

4.98

1.2

1.3

0.31

0.30

g/l

1.24

138

891

(3021691) Plasmodium malariae Ab [Titer] in Serum

5.41

4.90

2.2

2.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

129

1910

0.67

4.82

1.6

1.5

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

124

1843

0.67

4.73

12.3

13.4

0.62

mmol/l

0.06

110

1708

(3027008) Opiates [Presence] in Urine

1203

13629

0.88

4.69

1.7

2.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

7.14

4.64

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1208

13669

0.88

4.63

1.8

2.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.28

4.61

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

103

657

1.57

4.60

1.1

1.2

84.75

86.71

0.14

180

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.90

4.58

1.1

—

(3027944) Amphetamines [Presence] in Urine

1190

13447

0.88

4.48

1.8

2.0

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

576

1.60

4.45

1.5

1.4

34.88

20.23

4.05

533

(3016879) Cocaine [Presence] in Urine

1118

12674

0.88

4.42

1.8

2.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

917

7948

1.16

4.41

2.0

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

1203

13565

0.88

4.38

1.8

2.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

144

997

1.45

4.37

1.5

1.4

14.68

14.78

pmol/l

0.09

123

835

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

975

8501

1.15

4.33

2.2

2.0

4.94

10.87

iu/l

1.14

382

3546

(43055442) Apixaban [Mass/volume] in Serum or Plasma

391

1.71

4.27

1.4

1.6

125.97

106.67

ug/l

0.75

326

(40768800) Prostate Pathology biopsy report

360

4475

0.80

4.20

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1057

9303

1.14

4.11

1.6

1.4

11.05

10.30

u/l

0.93

873

7455

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

403

4934

0.81

4.08

1.5

61.50

59.95

ug/l

0.29

403

4934

(3001893) Eosinophils/Leukocytes in Pleural fluid

637

1.54

4.08

1.5

1.4

4.39

2.77

0.71

552

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

215

1.95

4.07

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

286

1.82

4.06

1.2

1.5

180.90

169.30

mmol/l

0.25

259

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

161

2.11

4.06

1.1

1.93

3.27

u/l

0.74

(3002079) Sodium [Moles/time] in 24 hour Urine

191

1408

1.36

4.06

1.3

1.2

153.94

160.67

mmol/24h

0.59

191

1408

(3011288) Drugs identified in Urine by Screen method Nominal

828

9508

0.87

3.99

2.3

2.9

—

(3014271) Vancomycin [Susceptibility]

148

1049

1.41

3.99

2.8

2.9

—

(3018291) Platelet Ab [Presence] in Serum

3.89

3.98

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

169

1229

1.38

3.93

5.3

2.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

510

1.59

3.89

1.7

1.46

1.20

nmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

212

1.93

3.88

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

112

760

1.47

3.83

1.5

1.4

49.67

64.01

3.56

638

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

404

1.66

3.82

1.1

1.0

0.05

0.22

u/ml

1.25

259

(4211845) Urine protein measurement

181

1348

1.34

3.65

5.1

2.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2987

27911

1.08

3.56

3.6

4.3

19.27

25.90

ug/l

0.68

2348

22415

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

7.77

3.55

1.0

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

4.76

3.54

8.1

2.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

124

2.18

3.52

1.1

1.2

0.34

0.81

umol/24h

0.99

(3025130) Human papilloma virus identified in Specimen

578

4932

1.17

3.49

2.1

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

119

838

1.42

3.39

5.8

6.6

24.21

25.14

mmol/l

2.20

108

767

(3028468) Fragments [Presence] in Blood by Light microscopy

5.71

3.33

1.0

2.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

103

709

1.45

3.33

7.6

8.0

5.93

5.95

kpa

0.08

642

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

661

1.47

3.30

1.1

68.04

75.19

0.69

175

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

399

0.43

3.29

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

384

3182

1.21

3.26

1.2

58.63

33.77

nmol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

386

1.61

3.19

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

595

1.48

3.14

2.0

2.8

1310.06

141.75

ug/l

0.48

595

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

142

1046

1.36

3.13

1.2

111.78

110.72

0.17

124

945

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

423

3557

1.19

3.09

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

344

2839

1.21

3.07

1.4

1.3

1.60

1.45

nmol/l

1.68

310

2559

(3027874) Urate [Moles/volume] in Urine

2.26

3.01

1.1

1.50

1.86

mmol/l

0.58

(3026657) Rickettsia conorii Ab [Titer] in Serum

2.89

3.01

1.1

—

371.20

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

262

1.72

3.00

1.1

1.0

0.06

0.04

u/ml

0.43

262

(3004446) Plasmodium sp identified in Blood by Light microscopy

315

1.65

3.00

2.6

2.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

182

1401

1.30

2.99

1.6

2.1

120.53

133.75

umol/l

0.19

100

676

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

674

5902

1.14

2.95

2.7

2.4

83.53

109.53

ug/min

1.50

379

3544

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

176

1.87

2.93

1.1

1.2

23.23

21.56

0.08

(40762814) Titanium [Mass/volume] in Blood

395

1.57

2.93

2.5

2.6

3.89

3.70

ug/l

0.14

141

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

149

1120

1.33

2.91

2.0

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

663

1.43

2.91

1.1

1.52

3.00

u/ml

0.56

574

(40760512) CD34 cells/cells in Bone marrow

5.38

2.86

1.6

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

641

1.44

2.85

7.6

7.9

6.32

5.58

kpa

0.99

641

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1258

11450

1.10

2.84

1.5

1.6

16.34

16.55

u/ml

0.03

210

2859

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

504

4339

1.16

2.81

1.3

0.22

0.24

nmol/l

0.14

270

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

101

1400

0.72

2.79

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

644

1.43

2.78

1.4

1.5

0.31

0.35

mmol/l

0.14

109

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.22

2.78

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

158

1.90

2.78

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2317

21667

1.07

2.75

1.2

121.25

142.14

u/ml

1.89

835

8205

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

140

1053

1.33

2.75

2.3

2.8

1.35

1.15

ug/l

0.54

132

1002

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

355

1.58

2.72

1.3

1.4

58.15

52.42

0.42

176

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.23

2.72

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.23

2.72

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.23

2.72

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.23

2.72

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.23

2.72

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.23

2.72

2.0

—

(3008037) Lactate [Moles/volume] in Venous blood

692

6109

1.13

2.71

3.7

3.1

1.42

1.56

mmol/l

5.25

668

5962

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

495

4271

1.16

2.69

1.3

0.61

1.68

nmol/l

1.25

477

4122

(3000034) Microalbumin [Mass/volume] in Urine

274

2248

1.22

2.66

3.1

3.0

48.12

48.34

mg/l

0.01

218

1584

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

100

2.10

2.57

1.1

1.3

1.18

1.12

u/field

0.05

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

208

1.73

2.51

1.3

1.4

15.21

15.92

pmol/l

0.12

181

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

174

1.78

2.40

1.0

22.09

16.55

u/ml

0.26

145

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

489

1.45

2.39

5.3

2.3

1.21

1.19

mmol/l

0.68

470

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1514

16311

0.92

2.39

2.5

3.6

40.56

54.60

u/ml

2.45

1453

15789

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

119

1.93

2.29

1.0

0.25

0.06

u/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1026

0.71

2.27

2.5

3.1

28.31

28.36

umol/l

0.02

782

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.22

2.26

1.3

1.8

73.33

132.36

ug/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

141

1.84

2.26

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1184

10879

1.09

2.25

1.6

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

2.24

0.0

7.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

976

0.71

2.23

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.27

2.23

1.1

1.2

32.13

32.43

mg/24h

0.03

(3013945) Hepatitis B virus e Ab [Presence] in Serum

179

1.73

2.20

1.1

1.6

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

196

1.68

2.13

5.3

3.5

11.39

9.69

0.14

(3024869) Neuronal Ab [Presence] in Serum

477

1.43

2.12

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

424

3693

1.15

2.12

1.2

1.3

0.19

0.21

nmol/l

0.97

334

2861

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

130

1.85

2.11

1.3

1.6

0.18

0.03

u/l

0.36

(3020123) Porphyrins [Interpretation] in Serum or Plasma

175

1.71

2.08

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

284

1.55

2.06

1.1

1.0

32.51

0.51

u/ml

0.52

139

(3020356) Listeria sp identified in Specimen by Organism specific culture

169

1.72

2.02

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

111

1.89

1.99

1.0

1.1

250.24

309.16

nmol/l

0.73

111

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.81

1.99

1.0

1.2

1.44

1.37

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

133

1.80

1.98

1.0

0.23

0.12

u/ml

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

193

1.66

1.98

1.1

1.6

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

3.33

1.96

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

141

1.77

1.95

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.02

1.94

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.35

1.94

1.7

1.4

1.98

2.03

mmol/24h

0.05

(3005570) Glucose [Moles/volume] in Urine

305

2613

1.17

1.93

2.2

1.9

1.10

27.38

mmol/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

188

1.65

1.89

1.0

1.1

14.03

8.21

u/l

0.30

188

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.85

1.86

1.1

1.0

0.39

0.07

u/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3816

36653

1.05

1.85

1.6

1.8

1.50

1.44

5.73

3311

32489

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

279

2384

1.17

1.84

1.1

9.40

7.82

iu/ml

0.30

646

(3018001) Oat IgE Ab [Units/volume] in Serum

221

1.58

1.83

1.1

1.0

2.89

0.24

u/ml

0.57

129

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

450

1.40

1.82

1.0

1.1

5.28

10.47

u/ml

1.37

450

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

4.16

1.82

1.0

23.60

21.75

umol/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

175

1.66

1.81

6.3

5.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

247

2095

1.18

1.80

1.1

7.61

2.05

u/ml

0.52

101

714

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

3.04

1.79

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

358

4085

0.87

1.79

1.4

2.87

3.75

ug/l

1.83

323

3578

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

151

1849

0.82

1.76

1.8

2.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

242

2054

1.18

1.75

1.2

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

565

1.34

1.74

1.3

1.18

mmol/l

0.16

565

(3007733) Chloride [Moles/volume] in Urine

2.03

1.74

1.4

1.5

101.07

79.42

mmol/l

0.80

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

218

0.46

1.74

1.0

1.1

1.09

1.23

mom

—

218

(3045683) HLA typing for celiac disease panel - Blood or Tissue

218

1836

1.19

1.73

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4222

43699

0.96

1.73

3.0

3.1

0.70

0.75

ug/l

2.28

2772

27369

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.00

1.68

1.4

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

503

5597

0.90

1.68

4.3

3.3

28.63

26.52

mg/l

0.73

363

3811

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

174

1442

1.21

1.66

3.0

6.7

3878.25

2996.97

u/ml

—

275

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7453

72665

1.03

1.65

4.7

5.3

2.26

2.87

ug/l

2.85

6764

66259

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

334

3804

0.88

1.65

1.4

1.3

7.32

7.13

mmol/l

0.53

309

3368

(3014599) Egg white IgE Ab [Units/volume] in Serum

237

2021

1.17

1.65

1.1

4.30

4.41

u/ml

0.02

540

(4146454) Self-monitoring of blood glucose

249

2895

0.86

1.64

2.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

463

1.36

1.58

7.1

7.0

10.77

10.59

0.21

463

(40762887) Creatinine [Moles/volume] in Blood

198

1.56

1.58

1.6

1.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.00

1.58

1.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.20

1.56

2.0

1.4

319.82

431.06

mg/24h

1.26

(40761995) Spermatozoa Progressive [#/volume] in Semen

717

0.72

1.55

3.2

3.3

39.71

44.59

1.00

717

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

716

0.73

1.54

6.5

6.6

9.98

8.74

0.68

716

(3036312) Salmon IgE Ab [Units/volume] in Serum

184

1.58

1.53

1.0

1.1

1.02

1.82

u/ml

0.33

135

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

23560

233635

1.03

1.52

40.2

18.3

331.07

332.58

g/l

123.88

23488

232409

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

525

0.68

1.49

1.3

1.2

75.31

69.06

ug/l

0.31

525

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

158

1886

0.84

1.47

1.0

344.44

330.58

ng/l

0.18

120

1374

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

136

1117

1.22

1.46

2.4

2.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.50

1.45

1.1

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

327

1.41

1.43

1.0

0.59

0.21

u/ml

0.83

208

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

727

1.27

1.41

2.5

3.0

103.65

110.42

ng/l

0.22

390

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

362

0.63

1.39

2.2

3.7

39.17

40.87

umol/l

0.14

315

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

410

0.66

1.38

1.0

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

111

1.71

1.38

1.2

1.1

2698.90

3930.33

ng/l

—

(3013336) Amino acids [Identifier] in Serum or Plasma

104

1.73

1.36

1.6

3.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

151

1.59

1.33

8.4

11.1

105.58

104.87

g/l

0.11

151

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

184

1.52

1.30

1.0

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

2.50

1.30

1.2

1.1

64.33

46.83

u/ml

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

2.50

1.30

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

643

6958

0.92

1.28

1.4

131.23

140.85

pmol/l

0.17

623

6802

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.88

1.28

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.78

1.26

1.0

4.42

14.16

mg/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

146

1.57

1.25

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

859

1.22

2.8

3.3

4.87

4.94

kpa

0.22

105

859

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

162

1893

0.85

1.22

1.0

40.75

41.07

ng/l

0.03

119

1356

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

860

1.22

1.21

2.8

3.3

11.19

10.43

kpa

1.05

105

860

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

148

1253

1.18

1.21

2.1

2.5

36.70

53.29

umol/l

6.33

128

1099

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

162

1890

0.86

1.20

1.0

812.63

751.90

ng/l

0.87

120

1329

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

213

1.45

1.19

1.3

1.2

91.45

103.72

ug/l

0.26

132

(44806420) Estimation of glomerular filtration rate

370

3338

1.11

1.19

2.8

2.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

129

1082

1.19

1.18

1.4

194.97

201.06

nmol/24h

0.02

129

1082

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

281

1.39

1.17

1.1

0.75

1.30

u/ml

0.36

209

(4094501) Cardiovascular stress test using bicycle ergometer

750

8017

0.93

1.12

1.1

—

(3032641) Amino acids panel - Urine

2.00

1.11

1.4

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

613

5684

1.08

1.10

1.4

1.3

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

319

1.35

1.10

1.6

1.4

12.56

13.99

0.15

167

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

511

4715

1.08

1.05

1.1

49.77

2910.07

iu/ml

0.67

115

970

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

245

1.39

1.04

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

183

2087

0.88

1.04

1.3

152.03

189.68

pmol/l

1.86

183

2087

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

106

1.60

1.02

1.1

1.0

0.09

0.04

u/ml

0.62

106

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

553

1.25

1.02

1.2

115.27

53.41

mg/l

0.31

387

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

393

3594

1.09

1.00

1.5

1.7

354.04

375.93

mu/l

0.31

330

2893

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

991

10452

0.95

1.00

1.7

1.8

—

22.16

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

121

1033

1.17

0.95

1.0

0.54

0.70

u/ml

0.36

115

1020

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

366

3351

1.09

0.93

1.0

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.61

0.93

1.0

7.15

0.22

u/ml

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

624

1.22

0.92

1.3

1.4

23.38

57.20

g/l

0.63

480

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

634

1.21

0.91

1.2

432.04

296.85

pmol/l

0.76

468

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

168

1478

1.14

0.89

3.2

2.1

199.63

201.37

u/l

0.12

168

1467

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1057

0.84

0.89

1.0

7.74

9.92

u/ml

0.58

675

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

168

1.43

0.89

2.8

2.2

8.14

20.38

3.02

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

202

1.39

0.88

1.4

1.5

30.18

37.12

0.41

135

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

315

1.30

0.87

2.8

2.3

0.78

0.61

u/field

0.44

315

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

304

2771

1.10

0.87

4.5

5.3

129.50

103.88

u/ml

0.22

104

936

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

547

1.22

0.87

1.2

2.0

2.67

2.74

ug/l

0.03

337

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

131

1137

1.15

0.86

1.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

240

0.67

0.85

2.1

3.2

4675.00

57.04

pmol/l

—

(44786800) Granulocytes/Leukocytes in Body fluid

255

1.33

0.85

1.3

33.36

23.31

0.91

195

(3016273) Islet cell 512 Ab [Units/volume] in Serum

212

1.37

0.85

1.1

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

238

1.34

0.85

1.1

1.0

0.55

1.00

u/ml

0.52

142

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

131

1501

0.87

0.85

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

1006

0.84

0.83

1.9

1.4

0.52

0.51

e9/l

0.08

1006

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

213

1.36

0.83

2.8

2.2

56.57

59.60

0.16

131

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

146

1.44

0.81

1.5

606.18

479.82

nmol/l

0.44

146

(3011897) Casein IgE Ab [Units/volume] in Serum

625

1.20

0.81

1.2

1.3

5.73

2.10

u/ml

0.30

618

(3026692) Albumin [Mass/volume] in Peritoneal fluid

708

1.19

0.80

1.5

1.4

11.48

13.60

g/l

1.33

539

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.70

0.80

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

105

1216

0.86

0.80

2.1

58.58

120.43

ug/min

1.03

262

(3014891) Appearance of Pleural fluid

267

1.31

0.80

1.4

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

795

0.83

0.80

1.5

1.4

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.67

0.78

1.3

1.5

0.43

0.39

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

392

1.25

0.78

2.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.50

0.77

1.8

2.0

277.00

243.71

ug/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

472

5040

0.93

0.77

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

484

1.22

0.76

2.1

2.3

8.09

7.47

mmol/l

0.25

281

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

2.08

0.74

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

596

1.19

0.73

1.1

1.2

3.30

5.99

u/ml

0.64

400

(3003577) Lead [Moles/volume] in Blood

263

0.72

0.69

1.8

1.4

0.22

0.25

umol/l

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

181

1635

1.11

0.67

1.5

1.6

1.41

1.26

nmol/l

0.83

134

1238

(3029396) Erythrocyte agglutination [Presence] in Blood

822

0.85

0.67

2.9

3.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

121

0.58

0.67

1.4

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

276

1.27

0.66

1.4

1.3

13.50

15.64

nmol/l

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

220

2011

1.09

0.65

2.3

3.6

189.13

144.94

nmol/l

0.44

208

1988

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

605

5742

1.05

0.63

3.1

2.1

1.02

0.85

nmol/l

5.14

526

4874

(3006567) Chloride [Moles/time] in 24 hour Urine

1.63

0.62

1.3

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

0.58

0.61

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

130

1.38

0.60

5.7

9.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

201

1842

1.09

0.59

1.1

0.49

1.08

u/ml

0.88

466

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1822

17729

1.03

0.56

1.9

2.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.58

0.54

1.0

1.1

—

(3006598) pH of Arterial cord blood

182

0.71

0.54

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

405

1.18

0.52

1.1

1.2

64.77

63.42

ug/l

0.11

405

(3013139) Helicobacter pylori Ag [Presence] in Stool

2025

20707

0.98

0.51

1.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5736

58039

0.98

0.50

4.0

4.3

21.74

21.97

0.52

2735

27084

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

140

1532

0.91

0.49

1.4

5.45

5.70

mmol/l

1.85

129

1446

(3020491) Glucose [Moles/volume] in Blood

214

1993

1.07

0.46

1.8

1.7

6.74

6.73

mmol/l

0.03

170

1447

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

236

1.23

0.46

1.0

1.1

0.20

0.23

u/ml

0.07

236

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

450

0.84

0.45

1.0

81.61

80.95

ug/l

0.04

350

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

123

1343

0.91

0.43

1.1

10.38

9.04

u/ml

0.09

236

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

185

0.76

0.43

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

185

0.76

0.43

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.40

0.42

1.0

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

140

1.28

0.41

1.1

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.38

0.41

1.4

2.4

1.96

3.51

mu/l

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

148

1369

1.08

0.40

1.6

1.8

2.22

2.66

u/ml

0.16

386

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

426

1.15

0.40

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

408

1.15

0.39

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

558

5372

1.04

0.38

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

282

2674

1.05

0.38

2.9

2.3

4.05

4.04

mmol/l

0.17

277

2654

(3043410) Blood group antigens tested for on Red Blood Cells

703

1.11

0.37

2.2

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

498

5170

0.96

0.37

1.5

0.36

0.38

nmol/l

0.21

376

3932

(3040794) Aluminum [Moles/volume] in Urine

1.35

0.37

1.2

0.66

0.39

umol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

693

0.89

0.36

1.0

1.1

29.90

28.83

iu/ml

0.06

693

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

197

1854

1.06

0.35

1.3

3.89

4.92

umol/l

3.96

175

1637

(3038515) Glucose [Moles/volume] in Venous blood

523

5042

1.04

0.35

4.1

3.2

7.17

7.49

mmol/l

1.97

505

4924

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

373

0.86

0.34

2.1

3.0

67.61

78.23

pmol/l

0.27

322

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

189

2004

0.94

0.34

1.6

7.89

7.81

mmol/l

0.20

181

1927

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

733

7113

1.03

0.34

1.1

2.42

2.03

u/ml

0.33

388

3848

(3051101) Glucose [Moles/volume] in Cord blood

393

0.86

0.33

3.6

5.7

9.79

8.34

mmol/l

0.50

393

(4038314) Semen analysis, post vasectomy

221

0.81

0.33

1.2

—

(4133840) Spirometry

777

1.09

0.33

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

296

0.84

0.33

1.4

1.2

21.07

20.78

mmol/l

0.12

240

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

328

0.85

0.32

1.2

6.18

5.89

mmol/l

0.31

328

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

242

0.83

0.32

1.4

1.2

45.85

46.48

mg/l

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

341

1.14

0.32

1.1

1.0

0.12

1.92

u/ml

0.85

162

(3035285) Chloride [Moles/volume] in Venous blood

280

2673

1.05

0.31

2.9

2.3

105.48

105.62

mmol/l

0.19

275

2653

(3009677) Dengue virus Ab [Presence] in Serum

128

1.25

0.31

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

147

1.22

0.30

1.1

1.0

66.81

0.40

u/ml

0.48

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

221

1.18

0.30

1.0

1.1

20.97

6.50

u/ml

0.69

135

(3010370) Gastrin [Moles/volume] in Serum or Plasma

476

1.11

0.29

1.3

1.9

66.89

47.72

pmol/l

0.45

403

(3033923) Metanephrine [Moles/time] in 24 hour Urine

573

1.10

0.28

1.1

0.67

0.81

umol/24h

0.53

282

(1761482) Bacteria [#/volume] in Urine by Culture

605

5879

1.03

0.28

4.6

4.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3310

32708

1.01

0.28

4.5

4.9

33.53

32.20

9.60

2472

22264

(3021387) Prolactin [Units/volume] in Serum or Plasma

1104

11252

0.98

0.28

1.7

282.91

304.90

mu/l

1.84

996

10210

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.27

0.27

1.0

1.1

2.25

2.81

—

(40758358) Immune stain study

128

0.78

0.27

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

337

1.13

0.26

1.1

0.08

0.84

u/ml

1.38

166

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

566

1.09

0.26

2.1

1.6

0.20

0.22

nmol/l

0.38

413

(3022475) Manganese [Moles/volume] in Blood

182

0.82

0.26

1.4

1.2

0.16

umol/l

0.34

182

(3034614) HLA Ag [Interpretation]

1.25

0.25

1.1

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

434

1.11

0.25

2.0

2.4

1.46

1.32

mmol/l

0.13

294

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1611

16334

0.98

0.24

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

408

1.10

0.23

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

244

2532

0.96

0.23

1.3

1.5

1.04

1.32

promille

2.26

191

1979

(37021550) Renin [Units/volume] in Plasma --upright

562

1.08

0.23

1.2

1.3

197.94

75.73

mu/l

0.41

423

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

473

0.91

0.22

1.3

1.7

4.82

5.30

nmol/l

0.21

453

(3014133) Dog dander IgE Ab [Units/volume] in Serum

502

5142

0.97

0.22

1.1

5.06

4.11

u/ml

0.47

249

2617

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

186

1781

1.04

0.22

6.2

7.2

139.35

56.13

ug/l

0.50

124

1145

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

865

1.06

0.21

2.3

1.9

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

103

0.78

0.21

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

315

1.11

0.21

1.1

0.48

1.01

u/ml

0.35

153

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.23

0.20

1.0

0.01

0.22

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

157

1505

1.04

0.19

1.4

1.9

49.82

628.91

pmol/l

0.93

234

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

491

1.08

0.18

8.9

7.1

67.93

69.49

0.18

379

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

206

0.87

0.18

1.0

1.1

—

(3049233) Organic acids panel - Urine

1.15

0.17

1.1

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.21

0.17

1.0

1.1

151.00

222.44

pmol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

263

2705

0.97

0.17

1.3

1.4

9.02

8.52

mmol/l

0.98

250

2567

(3033705) Calcium.ionized [Moles/volume] in Venous blood

271

2631

1.03

0.17

3.0

2.3

1.20

mmol/l

0.48

266

2611

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2318

23358

0.99

0.16

2.4

2.3

13.13

12.99

nmol/l

0.38

2117

21280

(3000285) Sodium [Moles/volume] in Blood

485

1.07

0.16

1.2

137.91

138.24

mmol/l

0.23

399

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

215

1.12

0.16

1.0

5.71

1.66

u/ml

0.72

173

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

169

1748

0.97

0.16

1.9

1.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

717

7053

1.02

0.15

2.0

1.9

198.23

201.12

pmol/l

0.35

683

6737

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.20

0.15

1.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

327

0.92

0.15

1.0

1.4

—

1.67

mmol/l

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.10

0.14

1.0

5.09

3.08

u/ml

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

497

4879

1.02

0.14

1.4

28.03

27.99

u/l

0.01

412

3982

(3008402) Methanol [Moles/volume] in Serum or Plasma

326

0.92

0.14

1.0

1.4

—

0.93

mmol/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.19

0.13

1.0

1.1

—

mmol/l

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

151

1.12

0.13

2.2

4.0

—

0.00

estimate

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1718

17027

1.01

0.12

1.5

1.4

27.71

27.36

iu/l

0.16

1470

14555

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

127

0.87

0.12

1.0

1.1

0.01

1.57

u/ml

1.83

127

(3010726) Horse dander IgE Ab [Units/volume] in Serum

593

5843

1.01

0.12

1.1

2.23

1.83

u/ml

0.41

327

3020

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

374

3801

0.98

0.11

1.4

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

605

5970

1.01

0.10

1.1

1.75

1.00

u/ml

0.99

274

2699

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

153

1489

1.03

0.10

1.7

1.6

4.61

8.85

nmol/l

0.51

125

1236

(3021162) Amylase [Enzymatic activity/volume] in Specimen

485

1.05

0.10

3.0

2.8

6859.23

1096.00

u/l

1.05

434

(3023430) Cat dander IgE Ab [Units/volume] in Serum

479

4850

0.99

0.10

1.0

1.1

3.73

4.93

u/ml

1.15

214

2222

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.14

0.10

1.0

—

(3001556) Androgen free Index in Serum or Plasma

281

1.07

0.09

1.2

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

1.04

0.09

1.0

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

174

1.09

0.09

1.1

1.0

81.31

0.31

u/ml

0.48

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

939

9461

0.99

0.09

1.8

1.9

41.52

41.16

nmol/l

0.16

921

9252

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

334

3288

1.02

0.09

1.7

2.1

28.27

25.52

ug/l

0.25

324

3229

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.11

0.09

2.0

2.1

24.75

29.54

—

(3022670) pH of Venous cord blood

0.79

0.08

1.2

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.77

0.08

1.0

176.00

163.11

g/l

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

411

1.05

0.07

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.82

0.07

1.1

19.85

47.90

umol/24h

—

(46235168) Fasting glucose [Moles/volume] in Blood

336

0.95

0.07

1.3

2.0

5.49

7.35

mmol/l

—

102

(3032868) Hemoglobin electrophoresis panel in Blood

275

0.94

0.07

1.4

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

568

0.97

0.06

1.6

2.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.11

0.06

1.0

0.01

0.08

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

879

1.02

0.05

2.4

1.8

5197.82

11525.45

e6/l

0.93

450

(3017509) Phencyclidine [Presence] in Urine

354

0.96

0.05

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

283

0.95

0.05

1.0

1.1

1.89

1.74

umol/24h

0.29

283

(3023487) Leukocytes [#/volume] in Peritoneal fluid

102

1033

0.99

0.03

2.3

2.0

381.49

2418.43

e6/l

1.51

689

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2141

21356

1.00

0.02

2.1

2.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

621

6224

1.00

0.02

1.1

4.96

5.03

u/ml

0.04

325

3375

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

322

3202

1.00

0.02

2.5

3.6

24.08

7.57

nmol/l

0.46

309

3097

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

431

4321

1.00

0.02

1.0

1.1

0.65

0.40

u/ml

0.41

152

1382

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

398

0.98

0.02

1.2

—

(3007463) Buprenorphine [Presence] in Urine

144

1.04

0.00

2.3

8.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

166

1.02

0.00

2.4

2.3

0.64

0.65

ug/l

0.03

166

(3042517) Benzodiazepines panel - Urine

406

1.01

0.00

2.4

2.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

358

1.00

0.00

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

227

1.01

0.00

1.6

1.8

41.39

49.14

umol/l

0.81

227

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.41

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.1

—

302.56

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.02

-0.00

1.0

1.5

2.62

2.06

g/l

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

148.17

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.99

-0.00

1.0

1.2

278.22

365.19

pmol/l

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

8.78

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

1.01

-0.00

1.1

2.7

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

10.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_L04AX – L04AX Other immunosuppressants

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

L04AX Other immunosuppressants

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for L04AX Other immunosuppressants (RX_L04AX)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints